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CHAPTER 1. GENERAL INTRODUCTION 
The bovine immunodeficiency-lit^e virus (BIV) was discovered over 25 
years ago, but the impact that this virus has on the cattle population remains 
unknown. This lack of understanding of the pathogenesis of BIV may be the 
result of several different things. First is the possibility that BIV has a very slow 
onset of disease. With most other lentiviruses, the disease outcome occurs 
many months or years after the individual is infected with the virus. Two 
examples of lentiviruses that have a long period before clinical disease are the 
human immunodeficiency virus (HIV) and the Maedi-Visna virus. The second 
possibility is that BIV may cause an immune deficiency type disease that allows a 
variety of other pathogenic agents to cause disease. This results in a variety of 
disease manifestations that are difficult to trace back to the original causative 
agent. Examples of this include HIV and the feline immunodeficiency virus (FIV). 
Both agents cause a primary immunodeficiency that allows many secondary 
pathogens to cause clinical illness. Having a variety of secondary disease 
conditions can obscure the original pathogen, and this may be occurring with 
BIV. Third, our current animal husbandry methods may be minimizing the effect 
of BIV infection. If BIV only causes disease after a prolonged incubation period, 
cattle may be culled from the herd before BiV causes disease. Fourth, perhaps 
the proper experimental methods are not being used to study this virus. 
Evidence from other viruses show a selection of the virus when it is cultured in 
vitro. With HIV, a loss of diversity is observed in the virus that is recovered by 
cell culture techniques (Kusumi et al., 1992). Attempts to culture the virus from 
naturally infected animals may be attenuating the virus, so that when cattle are 
2 
experimentally inoculated with cell culture adapted virus, it may be an attenuated 
virus that is not characteristic of what is observed in the field. Fifth, the isolates 
of BIV that are being used for experimental study are attenuated. Until recently, 
the only isolate that was available for study was the R29 isolate. Most of the 
scientific studies with BIV have used the R29 isolate, R29-derived isolates or 
reagents based on the R29 isolate. This reliance on R29 may have skewed our 
view of what BIV may cause in natural infections. Finally, the possibility that BIV 
is well adapted to its host and causes no clinical disease must be recognized as 
a possibility. For example, spumaviruses, another type of retrovirus, appear to 
be widespread in cattle, cat, simian and human populations, but cause no 
apparent disease. It remains a difficult puzzle to determine the role BIV may 
have In cattle disease. 
I believe that BIV is likely a disease causing agent, based on comparative 
studies with other Antiviruses. It causes a persistent infection in cattle and it 
appears to be widespread in the cattle population. The molecular biology of the 
virus shows many similarities with other lentiviruses including the presence of 
regulatory genes and methods of transactivation. My research, at least partially, 
involves the study of BIV as a potential pathogen. Of the six different possibilities 
that were addressed above as reasons why the role of BIV in disease maybe 
unclear, I am concerned primarily with points four and five. This includes the 
possibility that R29 may not represent BIV isolates that are present in naturally 
Infected animals and that an in vitro selection factor may be involved in 
attenuating BIV isolates recovered in cell culture. 
Examination of different viral isolates can be accomplished by a variety of 
different methods. Biologic differences, antigenic differences and sequence 
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differences are all methods of examining viral variation. Examining nucleotide 
sequence may be the most probing since biological and antigenic differences are 
the result of nucleotide changes. However, an examination by several of these 
criteria provides the most complete comparisons between different isolates of the 
same virus. 
Other lentivimses have been shown to occur as quasispecies, where 
almost every virion has a different nucleotide sequence when compared to each 
other. The quasispecies state is thought to occur mainly by the low fidelity of the 
reverse transcriptase enzyme that allows a high rate of error introduction into the 
transcription process. Thus allowing for the generation of diversity. Different 
quasispecies are then positively or negatively selected for and particular variants 
become more or less prevalent. These facts point out the value of studying both 
different field isolates of BIV as well as examining different variants of the R29 
isolate of BIV. 
In this thesis, R29-derived isolates and other field isolates are compared 
both for biological differences as well as nucleotide differences, with the intent of 
evaluating the potential role of BIV in disease. The first step in examining 
diversity is to obtain diverse isolates for study. BIV is very difficult to culture from 
naturally infected animals and only two additional isolates, other than R29, were 
isolated for biological comparisons. PGR amplification of different isolates is 
used to demonstrate some diversity among BIV isolates, and cloning and 
sequencing of PGR product is also used for sequence comparisons. For the 
purposes of examining the nucleotide sequences, selected areas of the lentiviral 
genome will be used for examination. In other lentiviruses the reverse 
transcriptase gene has been shown to be a highly conserved part of the genome. 
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The surface envelope gene has been described as having regions that are highly 
divergent in nucleotide sequence. Therefore in the worl< presented here, these 
two areas of the BIV genome are examined to assess the amount of sequence 
diversity of BIV. Evidence of biological variation in cell culture and after 
experimental inoculations are also examined for the cultured isolates. 
Dissertation Organization 
An alternative dissertation format was used for this dissertation, and it 
includes three papers that have been published, accepted for publication, or are 
in preparation for submission to scientific journals. Chapter 3, "Isolation and 
characterization of new wild-type isolates of bovine lentivirus", has been 
published in the Journal of Virology. Chapter 4, "Improved early and long-term 
detection of bovine lentivirus by a nested polymerase chain reaction test in 
experimentally infected calves", has been accepted for publication by the 
American Journal of Veterinarv Research. Chapter 5, "Identification of 
hypervariable and conserved regions in the surface envelope gene in the bovine 
lentivirus", is submitted to Virologv. For all three papers, I am the primary author 
and principal investigator. The dissertation also contains a general introduction, 
literature review, general conclusions and references cited in the literature 
review. The literature review encompasses parts of a review article, for which I 
was the primary author, entitled "Bovine lentivims (BIV): Diagnosis, prevalence, 
and pathogenesis", that was published in the Proceedings of the 98th Annual 
Meeting of the United States Animal Health Association. 
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CHAPTER 2. LITERATURE REVIEW 
Introduction 
The Antiviruses that are l^nown or suspected to cause disease in their 
natural hosts are listed in Table 1. The bovine immunodeficiency-like virus (BIV) 
remains a suspected pathogen, both by comparisons with other lentiviruses and 
by observations of experimental studies done with the virus. Table 1 divides the 
lentiviruses into the immune-mediated type diseases at the top, the 
immunodeficiency type diseases at the bottom, with BIV in between. If BIV does 
cause disease, it is unclear in which of the two groups of viruses BIV will belong. 
Table 1 Human and Animal Lentiviruses 
Equine infectious anemia virus 
Caprine arthritis encephalitis virus 
Maedi-Visna virus 
Jembrana disease virus 
Bovine immunodeficiency-iilce virus 
Human immunodeficiency virus Type 1 
Human immunodeficiency virus Type 2 
Non-human primate lentiviruses 
Feline immunodeficiency virus 
BIV is one of three different retroviruses that are known to infect cattle in 
the United States, and they include the bovine leukemia virus (BLV), the bovine 
syncytial virus (BSV) and the bovine immunodeficiency-like virus (BIV). A fourth 
retrovirus that infects cattle is the Jembrana disease virus (JDV), and it causes 
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an acute disease with high mortality in Bos javanicus cattle. JDV can infect Bos 
taurus and Bos indicus catXle, but it only causes a sub-clinical infection 
(Kertayadnya, et al., 1993). JDV is thought to be a lentivirus that is more closely 
related to BIV than to other lentiviruses, but it is thought to be restricted in 
distribution to Indonesia. The relationship of JDV and BIV appears to be 
analogous to the infection of humans by two lentiviruses, HIV-1 and HIV-2. This 
literature review will report what is known about BIV, and it will highlight some 
deficient areas of BIV research. 
Pathogenesis 
In examining the known pathogenesis of BIV, it is important to understand 
the experimental models that were used to gain this information. Four distinct 
categories of BIV inoculum have been used in experimental studies with cattle, 
with each inoculum giving unique results. Three of these inocula were derived 
from the original isolate of BIV and can be divided into low passage R29 (Van 
Der Maaten et a!., 1972), bovine viral diarrhea virus (BVDV) contaminated high 
passage R29 (Carpenter et al., 1992; Flaming et al., 1993:Van Der Maaten et al., 
1990; Whetstone et al., 1990), and BVDV-free high passage R29 (Flaming et al., 
1993; Suarez et al., 1993). The fourth category of inoculum is the recently 
described Florida isolates (Suarez et al., 1993). 
R29 was originally isolated from an eight-year-old dairy cow that had a 
persistent lymphocytosis, progressive weakness, and emaciation. Necropsy data 
showed a generalized hyperplasia of the lymph nodes and a mild perivascular 
cuffing in the brain (Van Der Maaten et al., 1972). Virus was isolated on fetal 
bovine spleen cell cultures and this inoculum was given to a group of colostmm-
deprived calves. The principal observations from this initial inoculation of a low-
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passage isolate was a transient mononuclear cell increase early in infection (10-
20 days post-inoculation [p.i.])i a second mononuclear cell increase later in 
infection (60-150 days p.i.), and clinical evidence of enlargement of 
subcutaneous lymphatic nodules (Van Der Maaten et al., 1972). 
The R29 isolates of today have undergone significant changes in the 
intervening twenty years. For example, the R29-1203 isolate has been passed 
through fetal bovine spleen cell cultures, canine thymocyte cell line, Madin-Darby 
bovine Kidney cell line, and is currently being maintained in fetal bovine lung cell 
cultures, and must be considered highly tissue culture adapted (Black, 1989; 
Bouillant et a!., 1989; Van Der Maaten et al., 1972; Whetstone et a!., 1991). The 
R29-derived isolates were also contaminated with a noncytopathic strain of 
BVDV during in vitro passage, and although BVDV-free isolates are available 
today, numerous animal studies were conducted with BVDV-contaminated 
isolates (Carpenter et al., 1992; Flaming et a!., 1993; Van Der Maaten et al., 
1990; Whetstone et al., 1990). Evidence of attenuation of the currently available 
R29 isolates is the loss of the transient mononuclear cell increase early and late 
after infection (Carpenter et al., 1992; Flaming et al., 1993, Van Der Maaten et 
al., 1990). R29-derived isolates still appear to generate a lymphoproliferative 
response, but it is not as great as that originally described (Carpenter et al., 
1992). The recently described Florida isolates, when examined in experimental 
inoculations, had some of the same observed clinical signs as the original BIV 
R29 isolate, including a transient mononuclear cell increase early in infection and 
a lymphoproliferative response, composed of a mild follicular hyperplasia. The 
late mononuclear cell increase was not observed in the very limited number of 
animals followed for long periods of time (Suarez et al.,1993). Further 
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experimental studies with tfie FL112 isolate have revealed that the early 
mononuclear cell increase observed in experimental inoculations was 
predominantly B cells (Suarez et al., 1993).® No large changes were observed in 
other cell populations during short-term infection with this isolate a 
Two infectious molecular clones of R29, R29-127 and R29-106, have been 
made and sequenced (Braun et a!., 1988; Garvey et al., 1990). R29-127 and 
R29-106 are very similar except for an 87 nucleotide base pair deletion In the 5' 
end of the surface envelope (SU) gene of R29-106 (Garvey et al.,1990). Ail of 
the R29-derived isolates sequenced or examined by PGR have a R29-106 
phenotype, with the 87 b.p. deletion. The R29-127 size genome was present in 
very low numbers, as measured in a Southern Blot analysis of the culture that it 
was cloned from (Braun et al., 1988). No evidence is available to support that 
the R29-127 size genome is still present in current viral stocks . This size 
difference in the envelope gene is further confounded by the observation that the 
Florida isolates and all other natural field isolates studied have a larger SU gene 
size than R29-127.'^ It appears that the R29 SU gene no longer represents the 
SU gene observed in BIV isolates that are out in the field. While R29 and its 
derivatives have been very valuable in the study of BIV, caution must be used 
when trying to interpret what a natural infection of BIV might cause in the way of 
Whetstone, C.A., Suarez, D.L., Harp, J.A., and Miller, J.M. 1994. 
Phenotypic and functional analysis of blood lymphocytes from calves 
inoculated with a low passage field isolate of bovine lentivirus (BIV). Proc. 
75th Conf Res Workers Anim Dis, Chicago, IL, November 14-15,1994. 
Suarez, D.L, and C.A. Whetstone. 1994. In vitro and \n vivo examination 
of the variation in size in the 5' region of the surface envelope gene among 
BIV isolates. Proc. 75th Conf Res Workers Anim Dis, Chicago, IL, 
November 14-15,1994. 
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clinical signs or possible disease as compared with what has been reported using 
R29. A further caution needs to be made for the BVDV contaminated isolates 
that were used in some studies, since BVDV is a known immunosuppressive 
agent early after infection, causing fever and lymphopenia (Potgieter, 1992). 
BIV causes a persistent infection in cattle with a detectable antibody 
response occurring typically two to four weeks post-inoculation (p.i.). Virus can 
be detected in peripheral blood by PGR as early as 3 days p.i. and it can 
continue to be detected for up to 3 years p.i. (Suarez et al.,1995). Vims can be 
isolated early after experimental inoculation, from 3 to 7 days p.i. (Whetstone et 
al., 1990; Suarez etal., 1993; Suarez etal., 1995). Antibody response peaks 
early in infection, and in many experimentally infected animals antibody levels to 
p26 and gpllO decline, sometimes to undetectable levels (Whetstone et al., 
1990; Onuma et a!., 1992; Suarez et al., 1995).° 
Several studies have examined the potential role of BIV as an 
immunosuppressive agent (Flaming etal., 1993; Martin et al., 1991; Onuma et 
al., 1992). BIV has not been demonstrated to cause a clinically apparent 
immunosuppression (i.e., greater susceptibility to infections with atypical 
pathogens) in experimentally inoculated cattle. Several reports have described 
specific dysfunctions of neutrophils, monocytes, and humoral response, but no 
dear trend has developed between difterent research groups (Table 2). For 
example, Martin (1991) described a decreased lymphocyte blastogenesis 
response 6 months p.i.(Martin et al., 1991). Flaming (1993) using a larger 
c Isaacson, J., Whetstone, C., Wannemuehler, Y., Roth, J.A., and Carpenter, 
S. 1993. Loss of antibody to the major viral core protein in cattle 
experimentally infected with bovine immunodeficiency-like virus. J Immunol 
150:234A. 
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sample size, demonstrated a slight increase in lymphocyte blastogenesis 
response at 4-5 months p.i. and between 19 and 27 months p.i. (Flaming et al., 
1993). Again the use of only R29-derived isolates, some contaminated with 
BVDV virus, have confounded some of these reports. Small sample sizes have 
also made analysis of the data difficult. The Martin study had two principals, the 
Onuma study had three principals, and the Flaming study had three to eight 
principals in each study group (Martin et al., 1991; Onuma et al., 1992; Flaming 
et al., 1993). To date, no convincing evidence for immunosuppression by BIV 
has been demonstrated, and therefore, the use of the name bovine 
immunodeficiency virus is probably misleading. However, further examination of 
^he role of BIV as an immunosuppressive agent is warranted because of its 
similarities to other immunosuppressive viruses. 
Table 2 Immune Studies on BIV Infected Cattle 
Study BIV Isolate Cattle # Reported Immune Dysfunctions 
Martin, 1991 R29a 2 Decreased lymphocyte blastogenesis response 
Onuma, 1992 R29a 3 Several monocyte functions decreased, slight delay 
in humoral response to mouse serum antigen 
Flaming, 1993 R29 3 None described 
Flaming, 1993 R29'> 4 Increased lymphocyte blastogenesis; decreased 
neutrophil ADCC<^ response 
Flaming, 1993 R29 and R29-106a 8 Decreased neutrophil ADCC and iodination 
response; increased lymphocvte blastoaenesis 
a BVDV status o1 inoculum unknown 
b BVDV contaminated inoculum 
c Antibody dependent cell mediated cytotoxicity 
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BIV has also been implicated as causing encephalitis, specifically causing 
perivascular cuffing in the brain. This histopathologic lesion is not 
pathognomonic of BIV infection and it has been associated with several other 
disease agents. The most commonly cited reason for believing BIV causes 
encephalitis is the data from the necropsy report of cow R29 (Van Der Maaten et 
a!., 1972). Other unsupported observations for brain lesions have been cited in 
review papers (Gonda et al., 1994). Anecdotal and other unpublished data 
suggest a potential role of BIV in causing perivascular cuffing in the brain, but no 
data at this time support an active BIV infection in the brain or evidence of 
clinically detectable encephalitis of infected cattle. 
BIV has often been cited as causing a lymphadenopathy (Gonda et al., 
1994; Gonda et al., 1987). Experimental inoculations do not support this clinical 
sign as being a common aspect of BIV infections. BIV has been reported to have 
a lymphoproliferative capacity in its ability to cause a transient mononuclear cell 
increase after infection and by the common observation of mild follicular 
hyperplasia in animals experimentally infected with BIV (Carpenter et al., 1992; 
Suarez et al., 1993; Van Der Maaten et al., 1972). In the initial experimental 
inoculation study by Van Der Maaten (1972), infected cattle were described as 
having palpably enlarged subcutaneous lymph nodes (Van Der Maaten et al., 
1990). However, a generalized peripheral lymphadenopathy was not described 
in this study or any other study of experimentally infected animals, and it is very 
much in doubt if lymphadenopathy is a clinically salient feature of BIV infection. 
The role of BIV as a disease agent is still debatable. One serological study 
has suggested a role of decreased milk production in BlV-infected animals 
(McNab et al., 1994). Other than in experimental studies, no other studies have 
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been reported that looked at objective parameters when comparing cattle 
infected with BIV. Serological studies must be carefully interpreted since the BIV 
infection may only be associated with another agent that is responsible for 
decreased milk production or some other clinical parameter. Results obtained 
using the attenuated R29 isolate may be masking the real disease role of BIV in 
natural infections. The question of whether BIV causes or does not cause 
disease is no closer to being answered today than it was 25 years ago. BIV 
elicits a characteristic response in cattle and it is assumed to cause a lifelong 
infection. Because most other lentiviruses cause disease, it is tempting to want 
to believe that BIV also causes disease. More research is needed to objectively 
examine the potential role of BIV in disease. 
Surrogate Models 
Because of the difficulty and expense of working with cattle, especially for 
longterm infections, a smaller model of BIV infection has been investigated. 
Experimental studies with mice, rats, guinea pigs, rabbits, goats and sheep have 
been described (Van Der Maaten et al., 1990: Gonda et al., 1990; Whetstone et 
al., 1991: Van Der Maaten et al., 1992; Pifat et al., 1992; Hirai et al., 1994; Smith 
et al,, 1994; Jacobs et al., 1994). BIV has only been shown to productively infect 
rabbits and sheep, as evidenced by a serologic response to BIV and PGR 
detection of provirus in blood from sheep and rabbits, and isolation of virus at 
necropsy from rabbits (Van Der Maaten et al., 1992; Hirai et al., 1994; Jacobs et 
al., 1994; Pifat et al., 1994, Smith et al., 1994). A single report of a natural 
infection with BIV has been reported in a sheep, based on an antibody response 
to the virus (Smith 1993). 
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Sheep have been experimentally inoculated with R29-derived isolates of 
BIV (Van Der Maaten et al., 1990; Smith et al., 1994; Jacobs et al., 1994). f\/lost 
of the inoculated sheep seroconverted to the virus, but virus could not be 
relsolated in cell culture from any of the inoculated sheep (Van Der Maaten et al., 
1990; Smith et a!., 1994; Jacobs et al., 1994). A nested PGR test was used in 
one study to document that provirus was present in peripheral blood from some 
of the sheep (Jacobs et al., 1994). No alterations in humoral immunity or cell-
mediated functions tests have been observed (Smith et al., 1994). 
Experimentally infected sheep, when compared to control sheep, were observed 
to have altered numbers of neutrophils, eosinophils, and several lymphocyte 
subset populations (Jacobs, 1994). BIV does not appear to replicate as well in 
sheep as it does in cattle, and clinical disease has not been observed. 
Rabbits were experimentally inoculated with R29-derived isolates of BIV 
(Van Der Maaten et al., 1992; Pifat et al., 1992; Hirai et al., 1994). Recovery of 
BIV by cocultivation of rabbit spleen cells with cells sensitive to BIV replication 
were described in all three studies (Van Der Maaten et al., 1992; Pifat et al., 
1992; Hirai et al., 1994). BIV was also recovered from several other organs in 
one study at necropsy (Pifat et al., 1992). PGR was also used to detect BIV 
provlral DNA from peripheral blood mononuclear cells and tissues (Pifat et al., 
1992; Hirai et al., 1994). Immunohistochemical staining in one study 
demonstrated BIV antigen in mononuclear cells from the spleen (Pifat et al., 
1992). Humoral immune response was decreased to some antigens and 
moderate lymphoid hyperplasia was observed in some of the BIV infected rabbits 
(Hirai et al., 1994). BIV does not appear to replicate as well in rabbits as it does 
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in cattle, and no clinical disease has been observed. Alternative models remain 
of limited value in the study of the pathogenesis of BiV in cattle. 
Molecular Biology 
BIV was originally thought to be in the same group of viruses as Visna-
Maedi virus on the basis of morphology of the virion, cytopathic effect in cell 
culture and the lymphocytic response observed in calves after experimental 
inoculation (Van Der Maaten et al., 1972). Electron microscopy studies of BIV in 
fetal bovine spleen cell cultures, demonstrated the extracellular virion had a 
diameter of 80 to 130 nanometers, the nucleocapsid formed during budding, and 
extracellular forms had an electron dense core (Van Der Maaten et al., 1972; 
Boothe et al., 1974). BIV was also shown to have reverse transcriptase activity 
with a preference for Mg2+ (Georgiades et a!., 1977). Additional studies with BIV 
showed an antigenic relationship of the p26 putative capsid protein (CA) with gag 
proteins of HIV, SIV and EIAV by homologous and heterolgous 
radioimmunoassay, and considerable nucleotide homology of the reverse 
transcriptase gene with other lentiviruses (Gonda et al., 1987). These were the 
initial studies that provided evidence that BIV was a retrovirus in the lentivirus 
subfamily, and further research has expanded on this initial information. 
With the sequencing of two infectious molecular clones of BIV, R29-127 
and R29-106, the genomic organization of BIV was determined. BIV has the 
characteristic retroviral organization of long terminal repeat (LTR)- gag-pol-env-
LTR (Garvey et al., 1990). The long terminal repeat (LTR) of the BIV genome 
has been described as having the TAR region important in the transactivation of 
this virus. Sequence analysis showed several other transcription factor binding 
sites, including NF-kB, API, AP4, and Spl binding sites. These binding sites can 
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act as promoters for viral transcription wfien cellular proteins bind to them. 
These promoter elements may increase transcription of the viral genome after 
the cell has become activated, and therefore they may be important in the 
replication of the virus. 
The first large open reading frame of the BIV genome is gag. The gag 
open reading frame contains three major structural proteins, the matrix protein 
(MA), capsid protein (CA), and the nucleocapsid protein (NC), that are analogous 
to proteins observed in other lentiviruses (Battles et al., 1992; Tobin etal, 1994). 
Three smaller proteins, identified as p2L, p3 and P2, have unknown functions 
(Tobin et al, 1994). The amino terminal, carboxy terminal and partial to complete 
amino acid sequences of these proteins have been determined, and the purified 
proteins have been used as antigens in protein immunoblots. The MA and CA 
proteins migrated near their expected molecular weight, but the NC protein 
migrated slower than would have been predicted (Tobin et al, 1994). All three 
proteins could be recogni2ed by some experimentally infected and naturally 
infected cattle serum (Whetstone et al., 1990; Tobin et al., 1994; Battles et al., 
1992). Proteins in the gag gene section are proteolytically cleaved from a gag 
precursor protein (pPrSSgagfj and from a gagi-po/polyprotein precursor 
protein(pPr''705asf-po/) (Battles et al., 1992). These precursor proteins have 
been detected immunologically in protein immunoblot studies (Battles et al., 
1992), and are cleaved into at least 6 different proteins that are present in the 
mature virion (Tobin et al, 1994). 
The gag gene or portions of the gag gene have been cloned and 
expressed in both E. coli and Baculovirus expression systems (Atkinson et al., 
1992; Rasmussen et al., 1990). The expressed proteins from both methods were 
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recognized by serum from experimentally and naturally infected cattle (Atkinson 
et al., 1992; Rasmussen et al., 1990). The baculovirus expressed gag protein 
has been used to screen cattle naturally infected with BIV in an ELISA format 
(Cockerel! et al., 1992; Coats et al., 1994). The E. coliexpressed gag protein, 
gags, was used to inoculate mice to make monoclonal antibodies to the gag 
protein. Two monoclonal antibodies were characterized and shown to recognize 
the p26 CA protein of BIV (Wannemuehler et al., 1993). 
The second large open reading frame of the BIV genome is the pol gene. 
This includes the reverse transcriptase (RT) enzyme, whose activity was one 
criteria for inclusion in the retrovirus family (Georgiades et al., 1977; Kashanchi et 
al., 1991). The p72 protein, the putative RT enzyme, has been detected with 
sera from experimentally and naturally infected cattle (Whetstone et al., 1991). 
The remainder of information about the po/gene is based on analysis of 
nucleotide sequence. The po/gene is thought to be translated as a po/precursor 
that is part of the PR^70gag-pol precursor (Garvey et al., 1990). The pol proteins 
are thought to be translated after a ribosomal frameshifting event at a poly-A site 
at the beginning of the po/gene (Garvey et al., 1990; Battles et al., 1992). Three 
separate proteins are thought to be made by the cleaving of the pol polyprotein 
into a protease (PR), RT, and endonuclease/integrase proteins (Garvey et al., 
1990). The predicted RT gene of BIV has been compared to other lentiviral RT 
genes, and highly conserved motifs have been observed (Gelman et al., 1992). 
Phylogenetic tree analysis showed that BIV is a distinct member of the lentivirus 
family (Gonda et al., 1994). Sequence comparison of R29-derived isolates of 
BIV and the recently described Florida isolates of BIV have shown greater than 
92% sequence homology (Suarez et al., 1993). 
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The third large open reading frame is the envgene, which encodes the 
surface envelope gene (SU) and the transmembrane gene (TM) (Garvey et al., 
1990). A 3.8 kb RNA transcript has been identified that encodes the env proteins 
(Oberste et al., 1991). The start site for the SU gene is thought to originate from 
the second ATG start site. Several studies further suggest this to be the case, 
but it has not been proven (Rasmussen et al., 1992; Oberste et al., 1991; Chen, 
P.et al., 1994). The SU and TM proteins are thought to be proteolytically 
cleaved at a RKPR motif, and this proteolytic cleavage region is similar to that 
observed in other Antiviruses (Garvey et al., 1990). Both proteins are 
glycosolated and can be detected with immune serum on a protein immunoblot 
(Whetstone et al., 1991). Recombinant proteins have been made in E.coliand 
baculovirus expression systems that react with BIV immune serum (Chen, P. et 
al., 1994; Rasmussen et al., 1992). Three molecular clones of R29 have been 
made and sequenced, including R29-127, R29-106, and R29-ND (Garvey et al., 
1990; Nadin-Davis, Genbank). All three envgenes have high sequence 
similarity, with the only large difference being a 87 b.p. deletion of the 5' end of 
the SU gene in R29-106 and R29-ND. The larger R29-127 has been used as the 
prototype for BIV, even though it was present in only very low levels in the cell 
culture from which the molecular clone was made (Garvey et al., 1990). 
Complex retroviruses are defined as having regulatory proteins important 
in the replication life cycle of the virus. Two BIV proteins, tat and rev, have been 
shown experimentally to be of some importance in the regulation of the virus, and 
will be discussed in greater detail. Another regulatory protein, vif, has been 
identified based on similarities with other lentiviral vif proteins, but little 
experimental data has been reported about this protein (Oberste et al., 1992; 
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Oberste et al., 1991). It Is thought to be transcribed from the central region of the 
BIV genome, overlapping the 3' end of the polymerase gene (Oberste et al., 
1992). A 4.1 kb transcript was Identified that may encode the vif gene, but this 
could not be confirmed (Oberste et al., 1991). Three additional proteins, 
predicted or reported as unpublished observations, include Tmx, Vpw and Vpy 
(Garvey et al., 1990; Gonda et al., 1994). All the regulatory proteins are 
produced by alternative splicing of mRNA from the central region of the BIV 
genome and a region downstream of the TM gene (Oberste et al., 1991; Gonda 
etal., 1994). 
A transactivation protein (tat) was predicted based on sequence 
similarities with the HIV tat gene (Garvey et al., 1990). Atransactivating gene 
was shown to be present in BIV Infected cells by using a chloramphenicol acetyl 
transferase (CAT) reporter system that could increase transcription up to 7 fold 
over controls (Pallansch et al., 1992). The tat transcript was shown to be a 
spliced RNA transcript of 1.4 l<b (Oberste et al., 1991). Two exons, both from the 
e/if reading frame, form the tat transcript, but the tat protein is believed to be 
transcribed from the first exon only (Liu et al., 1992). The tat protein is thought to 
have a nuclear localization motif as well as an arginine rich region that binds to 
an RNA transcript (Liu et al., 1992; Chen, L et al., 1994). The BIV 
transact!vating response element (TAR) was shown to be in the BIV LTR region 
downstream of the transcription start site, and is predicted to form an RNA stem 
loop structure that is recognized and bound by the tat protein (Carpenter et al., 
1993). An arglnine-rich region of the tat protein was shown to bind to the BIV 
TAR element with high affinity and specificity. This binding does not require any 
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cellular proteins for this interaction, and therefore it is different from HIV tat 
binding to the HIV TAR element (Chen, L et al., 1994). 
The BIV rev protein is also thought to be a spliced transcript with two 
coding exons, both overlapping the envgene (Garvey et al., 1990; Oberste et al., 
1991). A 1.7 kb RNA transcript was described that is thought to be the rev 
transcript (Oberste et al., 1991). The rev gene is phosphorylated and was shown 
to localize in the nucleus after translation (Oberste et al., 1993). The rev gene 
regulates the production of both gag protein as well as env protein (Oberste et 
al., 1993). BIV rev probably plays an important role in the regulation of the BIV 
life cycle, and it is important in the production of virions from the infected cell 
(Oberste et al., 1993). 
Diagnosis 
Isolation of BIV from field samples has been very difficult at best. 
Numerous attempts to culture the virus have resulted in failure. Currently, only 
two published reports have documented the successful culturing of BIV from 
naturally infected cattle, allowing three different isolates to be available for study 
(Van Der Maaten et al., 1972; Suarez et al., 1993). These isolations were made 
from cocultivation of primary fetal bovine spleen or lung cell cultures with blood 
buffy coat cells from infected cattle. However, this same technique has proven to 
be unsuccessful in other attempts at isolation from l<nown naturally and 
experimentally infected animals. The prominent cytopathic effect (CPE) that has 
been described for BIV in cell culture is syncytial formation after multiple blind 
passes. However, it has talon up to 8 blind passages in cell culture before CPE 
is observed, which results in a 3- to 6-week lag time before infection with BIV 
becomes detectable in clinical samples (Van Der Maaten et al., 1972; Suarez et 
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al., 1993). The use of a reverse transcriptase assay, a syncytial assay, and 
immunoperoxidase assay have also been used to monitor for BIV infection of cell 
cultures (Gonda et al., 1987; Onuma et al., 1990; Horzinek et al., 1991; 
Kashanchi et al., 1991; Geng et al., 1992; Nadin-Davis et al., 1993; 
Wannemuehler et al., 1993; Jacobs et al., 1994). Contamination of cell cultures 
with more aggressive viruses, like bovine herpesviruses and bovine syncytial 
virus, is common (Van Der Maaten et al., 1972; Suarez et al., 1993). 
Experimental testing with R29-derived isolates has demonstrated that BIV does 
not grow well on established cell culture lines and it is best propagated and 
isolated on primary fetal bovine cell cultures, based on antigen production as 
measured by agar gel immunodiffusion and radial immunodiffusion tests 
(Whetstone et al., 1991). The optimum conditions forculturing wild-type virus, 
however, may still remain to be identified. There have been reports that BIV has 
been grown on heterologous species cell cultures such as a canine thymocyte 
cell line (Bouillant et al., 1989). These cell cultures were not compared to the 
fetal bovine primary cell cultures either in sensitivity for virus recovery or in the 
production and processing of viral proteins. Currently available techniques in 
virus isolation are still too unreliable to be of routine diagnostic value. 
Methods reported for the serodiagnosis of BIV include: 
immunofluorescence (Amborski et al., 1989; Black et al., 1989; Whetstone et al., 
1990; Horzinek et al., 1991; Muluneh, 1994), Western immunoblot (Whetstone et 
al., 1991; Forman et al., 1992; Jacobs et al., 1992; McNab et al., 1994; Hirai et 
al., 1994), enzyme-linked immunosorbent assay (ELISA) with whole virus 
antigens (Onuma et al., 1992) or recombinant antigens (Cockerell et al.,1992; St. 
Cyr Coats et al., 1994), and a focus immunoassay (Muluneh, 1994). 
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Immunofluorescence, usually performed as an indirect fluorescent 
antibody assay (IFA), is a sensitive and specific test. However, there are multiple 
limitations to using this assay. The test has to be carefully controlled to assure 
that all of the reagents used, including cell cultures, reference sera and 
conjugates, are free of bovine viral diarrhea viais (BVDV). The pattern of 
cytoplasmic fluorescence produced with both BIV and BVDV are 
indistinguishable. Since BVDV is a common virus among cattle, as well as a 
common contaminate in cell culture, it could account for a high false positive rate 
of diagnosis. Sera from field cases, especially from older animals that have been 
exposed to multiple vaccinations and bacterial and viral antigens, tend to have a 
high, nonspecific background that interferes with the interpretation of the test. In 
order to avoid this, sera must be diluted, often times so much so that specific 
antibodies can no longer be detected, accounting for false negatives or a no test. 
Lastly, reading IFA accurately demands highly skilled personnel and expensive, 
specialized equipment. 
The BIV Western immunoblot is a highly specific and sensitive test that 
can detect the presence of viral polypeptide-specific antibodies. Since antibody 
reactivity is directed to specific viral polypeptides of known molecular size, results 
can be visualized with a high degree of confidence. Although the Western 
immunoblot is a very good assay, it is too cumbersome to be used for processing 
large numbers of samples. A second drawback to the test is that it is difficult to 
prepare antigen that has sufficient amounts of eni/glycoprotein to give a reliable 
test. Different cell cultures express viral glycoproteins at varying levels, but even 
under optimal conditions only a small percentage of total viral protein is env 
glycoprotein (Layne et al., 1992). This is compounded by the fact that the 
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glycoprotein is fragile and easily lost during preparation if care is not taken to 
minimize that loss. The two major polypeptides that are diagnostic for BIV are 
the major core p26 gag and the gp110 env (Whetstone et al., 1991). If viral 
antigen preparations are not optimized for glycoprotein, then Western 
immunobiot reactivities are limited to p26. This could be somewhat averted by 
using recombinantly prepared gag and eni'proteins (Rasmussen et al., 1990; 
Rasmussen etal., 1992; Wannemuehler et al., 1993). We know from 
experimentally inoculated cattle, that reactivity to p26 commonly diminishes or 
falls below detectable levels^ (Whetstone et al., 1992; Suarez et al., 1995). Even 
recombinant antigens cannot help if antibody levels in the animal have fallen 
below detectable levels. 
A third type of serological test is the ELISA. Antigens for the ELISA can be 
prepared from either whole virus or recombinantly-derived material. Although this 
test is easily used with large numbers of samples, the specificity is usually 
confirmed by a Western immunobiot assay. ELISAs are often highly sensitive 
tests, but because of nonspecific reactions from bovine serum samples due to 
extraneous proteins in the antigen preparation, false positives are common. The 
use of recombinant gag antigens have been reported (Cockerell et al., 1992; St. 
Cyr Coats et al., 1994). However, this test has never been described in detail 
and validation methods have not been published. Complete correlation between 
ELISA and Western immunobiot assays is probably not possible because there 
are basic differences in the two tests, but the Western immunobiot test is 
Isaacson, J., Whetstone, C., Wannemuehler, Y., Roth, J.A., and Carpenter, 
8.1993. Loss of antibody to the major viral core protein in cattle 
experimentally infected with bovine immunodeficiency-like virus. J Immunol 
150:234A. 
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considered more specific because antibody to specific viral proteins can be 
compared. 
With all of these assays it must be remembered that each type of test 
detects antibodies to different types of antigens. Comparisons of the different 
serodiagnostic tests have not been made. With experience borrowed from HIV, 
the ELISA test can be a very sensitive test for lentiviruses, but a confirmatory test 
with high specificity in the form of a Western immunoblot is required to prevent 
false positives. The IFA, because of the difficulties in interpretation, has become 
less prevalent as a routine diagnostic test for this virus. Our lab primarily uses 
the Western immunoblot assay for final determination as a serodiagnostic test. 
As with HIV, it is advisable to use more than one type of test to confirm the 
serological status of a sample. 
A hot start single reaction PGR (Nadin-Davis et al., 1993) and a nested 
PGR (Suarez et al., 1995) have both been described for the detection of BIV-
infected cattle. Both of these tests are used to detect proviral DNA. Both 
techniques rely upon the use of multiple primer sets to amplify different areas of 
the BIV genome to overcome the potential of the primers missing amplification of 
variant virus strains. The nested PGR test was shown to be more sensitive in 
other retroviral systems because of the greater number of cycles involved. This 
is an important feature since ientivirus-infected animals are thought to usually 
have a very low number of infected cells in peripheral blood. Both techniques 
use a Southern blot hybridization assay for confirmation of PGR product, but only 
the single reaction PGR test requires the Southern blot test for maximal 
sensitivity of the test. Direct comparisons between these two tests have not been 
made, and it is not possible to tell if one has a clear advantage over the other. 
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Nested PGR can detect BIV both early after infection, before virus specific 
antibodies appear and before virus can be isolated, and later in infection when 
antibodies fall below detectable levels and virus is not easily recovered (Suarez 
et al., 1995). Neither PGR test was used to examine large numbers of naturally 
Infected animals. These tests have a great potential, but currently they are still 
untested in the field. Even a successful PGR test, however, does not lend itself 
to processing large numbers of samples and quality control assurances must be 
high to prevent false positives. 
Prevalence 
The prevalence of BIV infection in United States cattle herds is unknown 
and with existing diagnostic technologies, we can only estimate the true 
prevalence. Various serologic studies have been reported that show that BIV is 
widely distributed, being present in the United States, Canada, Australia, New 
Zealand, Netherlands, Germany, and other foreign countries (Table 3) (Amborski 
et al., 1989; Black et al., 1989; Van Der Maaten et al., 1990; Horzinek etal.,1991: 
Horner etal., 1991; Cockerell et al., 1992; Forman et al., 1992; Jacobs et al., 
1992; McNab et al., 1994; St. Gyr Coats et al., 1994; Muluneh, 1994). 
The three largest seroprevalence studies, using samples randomly 
selected from available sera from across three countries, detected antibody 
levels of 1.4 % to 5.5% (Black, 1989; Horzinek et al., 1991; McNab et al., 1994). 
McNab's (1994) study of Canadian cattle also reported a herd infection rate of 
18.1%.(McNab et al., 1994) Other studies of individual herds have shown a 
higher incidence of infection using a recombinant ELISA system (Cockerell et al., 
1992; St. Gyr Coats et al., 1994). 
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Table 3 BIV Serologic Studies 
Study Method # Cattle % Positive Country 
Amborski et al., 1989 IFA 235 2% U.S.A. 
Black, 1989 IFA 1997 4% U.S.A. 
Van Der Maaten, 1990 WB 85 25.8% U.S.A. 
and Whetstone, 1990 
Horzinek et al., 1991 IFA & WBa 957 1.4% Netherlands 
Horner, 1991 WB 93 12% New Zealand 
Cockerell et al., 1992 ELISAb 95 21% U.S.A. 
Forman et al., 1992 ELISAC & WB 120 7-17%d Australia 
Jacobs et al., 1992 WB 39 23% Canada 
McNab et al., 1994 WB 928 5.5% Canada 
StCyr Coats et al., 1994 ELISAb 221 50% U.S.A. 
Muluneh, 1994 IFA & cell 380 6.6% Germany 
-ELISA 
Indirect Flourscent Antibody test (IFA), Western Blot (WB), Enzyme-Linked 
Immunosorbent Assay (ELISA) 
a. Screened with IFA, and confirmed with WB 
b. Recombinant gag antigen ELISA 
c. Whole virus antigen ELISA 
d. Overall seropositive rate was not given 
Detailed comparisons of the different serologic detection methods have 
not been made. Only one study has reported comparisons between two different 
BIV serologic detection methods, the IFA and Western immunoblot tests. These 
tests, when comparing the same serum samples, showed a 6.7% positive rate by 
IFA, and when WB was used as a confirmation test, only 1.4 % positive. When 
selected IFA negative samples were tested by WB, some samples were found to 
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be positive (Horzinel< et al., 1991). In tliis study the two methods did not 
correlate well with each other, and with no "gold" standard for the detection of 
BIV infection, it is not clear which is the better technique. 
With the various studies that have been completed, a statement of 
seroprevalence of BlV-infected animals cannot be made. From the available 
data, the number of infected cattle in an individual herd may be very high, but the 
overall prevalence in the United States is probably much lower. It has been 
hypothesized that the rate of infection may be much higher in Southern states for 
a variety of potential reasons, but it is not possible to conclusively make this 
claim with the available data. The largest survey of cattle, by Black (1989), was 
almost exclusively of cattle from Southern states, and showed a lower overall 
incidence of antibody detection as compared to McNab's (1994) Canadian study, 
which appears to contradict the hypothesis of a higher seroprevalence in the 
South (Black, 1989; McNab et al., 1994). The studies did use different detection 
methods (IFA and Western immunoblot) which makes direct comparison of the 
two studies difficult. The incidence of BIV infection in dairy cattle has also been 
thought to be higher than in beef cattle, but again the published data does not 
support this idea (Amborski et al., 1989). The available data does support the 
hypothesis that BIV is widely distributed, and suggests that it is probably present 
in every country with a large cattle population. 
Public Health Concerns 
The relatedness of BIV to HIV has caused some concern about the 
potential public health implications of this virus in our food supply. Several 
studies have examined the ability of BIV to grow in human cell lines. BIV was 
shown to grow in cultures derived from malignant bone marrow cells (Georgiades 
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et al., 1978). However, other studies using primary human and embryonic cell 
cultures showed no evidence of active infection (Kashanchi et al., 1991; 
Georgiades et al., 1978). No evidence of an active infection of humans has been 
reported, even after accidental inoculation with the virus (Whetstone, et al., 
1992). Some sera from BIV infected cattle can recognize some HIV proteins on 
Western immunoblot tests, and some high-titered sera from HIV infected patients 
can recognize BIV proteins on Western Immunoblot tests (Jacobs et al., 1992). 
The role that this cross-reaction may play in the persistently indeterminate 
response of humans to the HIV Western blot assay was examined with no 
evidence that response to BIV antigens was the source of the indeterminate 
reaction (Whetstone et al., 1993). Current evidence suggests no role for BIV as 
being a public health risk (Brownlie, 1994). 
Viral Variation 
Variation of BIV in vivo or in vitro has not been extensively studied. 
However, retroviruses, and lentiviruses in particular, are known to be highly 
variable in nucleotide sequence, with substitutions, frameshift mutations, 
deletions, insertions, and recombinations being described (Temin, 1993). This 
sequence diversity affects how the virus functions and interacts with its host. The 
source of the variation for retroviruses, and lentiviruses in particular, will be 
described as well as how this affects the distribution of mutations in the viral 
genome. 
Retroviruses are RNA viruses that go through a DNA intermediate stage 
during their life cycle. Reverse transcription, transcription of DNA from an RNA 
template, is one of the most important sources of retrovirus variation that has 
been described. The retrovirus virion consists usually of two copies of the 
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positive sense single-stranded RNA viral genome, RT and a host-derived tRNA 
that is used as a primer. Upon entering a permissive cell, the virion uncoats to 
release the RNA genome, RT enzyme, and the tRNA. The tRNA binds to the 
primer binding site on one of the RNA molecules and initiates first strand 
synthesis by the RT enzyme. The negative sense DNA strand is made from the 
RNA template first, the RNA template is digested by ribonuclease H and the RT 
uses the negative sense DNA as the template to synthesize the complementary 
positive sense DNA to form double stranded DNA. The double stranded DNA is 
integrated into the host cell genome, and the integrated provirus is the template 
when virion RNA is produced to complete the life cycle (Dahlberg, 1988; 
Williams, etal. 1992). Reverse transcription has two steps where errors are most 
commonly introduced. First, the making of the negative-sense strand of DNA 
from the positive sense RNA found in the virion. Second, the use of this 
negative-sense strand of DNA as a template for replication of the positive-sense 
strand of DNA (Williams, et al., 1992; Temin, 1993). The RT enzyme is 
particularly error prone, because like other RNA dependent transcriptases it lacks 
3-5' exonuclease activity. 3-5' exonuclease activity is an important error 
correcting mechanism built into many DNA dependent DNA polymerases. The 
first step of reverse transcription is thought to be the most error prone, since no 
host error correcting mechanisms are available. If, during the transcription of the 
positive-sense DNA strand, an error is made when the double stranded DNA is 
integrated into the host genome, the host's DNA error correction mechanisms are 
available to correct the error. The host, however, cannot distinguish which is the 
correct strand of DNA and the error has a 50% chance of being corrected to the 
original state. Another place for errors to be introduced is when full length viral 
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genome is transcribed by liost DNA dependent RNA polymerases. These 
enzymes also lack 3'-5' exonuclease activity and can introduce errors at 
appreciable rates (Williams, etal., 1992; Temin, 1993). 
The RTs found in different lentiviruses are similar, but they do have 
quantitative differences in fidelity. For example, spleen necrosis virus has a 
higher error rate than bovine leukemia virus in similar fonward mutation assays 
(Mansky et al., 1994). The fidelity of the HIV RT was measured to be one-third 
that of other retroviruses studied in an in vitro system (Takeuchi et al., 1988). 
The template can also affect the type and rate of mutations. Homo-
oligomeric runs often cause frameshift mutations. Poly-A runs were described as 
having particularly high error rates (Bebenek et al., 1989: Williams et al., 1990; 
Burns et al., 1994). Particular substitutions were observed more often, including 
the guanine to adenine substitution. This substitution is sequence oriented with 
the NGAN sequence being the most likely to have the guanine to adenine 
mutation (Bebenek et al., 1989; Vartanian et al., 1991). Strand jumping by RT 
from a small repeat to another on the same strand or on another strand was also 
postulated as a means to insert or delete regions of sequence (Temin, 1993). 
Recombination was shown to have a role in the variation of retroviruses 
(Vartanian et al., 1991; Stuhlmann et al., 1992; Kellam et al., 1995), with both 
heterologous and homologous recombination demonstrated in different retroviral 
systems. Recombination can occur in the virion between the two RNA genomes 
that are copackaged, usually during the reverse transcription step. The 
packaging of heterolgous RNA genome is also an important component for 
recombination to occur. In one retroviral experimental system, recombination 
occurred at about 10'4 per virus replication cycle (Stuhlmann et al., 1992). 
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Different recombinants were observed in HIV that had effects on the evolution of 
the virus (Kellam et a!., 1995; Vartanian et al., 1991). 
The sources of retroviral variation have been documented, but the 
importance of this variation has not been addressed. While variation occurs 
essentially randomly throughout the retroviral genome, specific areas of the 
retroviral genome may have high variability and other areas may have low 
variability. For example, five regions of the surface envelope gene of HIV were 
described as hypervariable (Modrow et a!., 1987). A hypervariable region is 
defined as having much higher sequence variation than the rest of the gene. 
Relatively conserved regions were also found in the SU gene of HIV. The RT 
gene was one of the most conserved regions of the HIV genome (Gelman et al., 
1992). The difference in variability between these two regions was not that one 
gene was more mutable than the other gene, but that one protein could tolerate 
greater variability than the other protein and still function properly. Mutations that 
give the recipient a selective advantage in its environment have a greater chance 
of being replicated. Selection of variants by it's environment drives the apparent 
concentration of mutations to particular regions of the genome. 
The RT gene, even as one of the most conserved regions of the viral 
genome, is under a constant selection pressure from the environment. The 
selection process is most apparent when antiviral drugs targeted to the RT 
enzyme are given to the patient or added to culture medium in vitro. It has been 
well characterized that HIV will become resistant to AZT, a nucleoside inhibitor of 
HIV, usually in less than a year in the patient (Kilby et al., 1994; Kellam et al, 
1995). Resistance to AZT occurs much faster than in a year, but AZT resistant 
mutants require a time period to become the predominant virus type in the 
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patient. The patient has a decreasing clinical response to the treatment over 
time as the antiviral drugs become less effective at inhibiting viral replication. 
HIV was shown to be resilient in that the RT enzyme became resistant to a 
number of antiviral drugs and still remained active in the life cycle of the virus. 
The surface envelope gene has well described hypervariable genes that 
have been shown to be important in many aspects of the lentivirus lifecycle. One 
selection factor on these hypervariable regions is the host immune response. 
The hypervariable regions are predicted to be and have been demonstrated to be 
surface epitopes of the SU gene. With HIV, the third hypervariable region is 
important in the virus's binding to the hosts CD4 receptor (Levy, 1993). Antibody 
to the V3 region of the SU gene can block this binding and neutralize the vims. 
However, viral mutation allows selection of viral variants with altered V3 regions 
allowing it to avoid antibody binding and escape neutralization. Escape from the 
antibody response is also thought to play an important role in disease 
pathogenesis of equine infectious anemia virus infection of horses (Salinovich et 
al., 1986). The virus causes an acute infection of horses, and the horse mounts 
an immune response and recovers. However, the virus is not eliminated and 
variants arise that evade the host immune response ultimately causing a 
reoccurrence of clinical symptoms (Salinovich et al., 1986). Immune response is 
not the only selection factor that directs the location of mutations, but it is one 
aspect that has been observed in several lentivirus systems. 
Sources of viral variation have been described and some of the selection 
pressures that affect this variation have been described, but another term, 
quasispecies, needs to be introduced. Most RNA viruses, because of their high 
variability, are thought to occur in a quasiviral state, where literally every virion is 
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different from every other virion (Nowak et al., 1991; Williams et al., 1992; Duarte 
et al., 1994). For HIV, the rate of mutation occurrence has been estimated at 
about 1 in every 10,000 bases transcribed (Takeuchi et al., 1988; Ji et al., 1994). 
The virus is about 8.5 kilobases in size, so after every round of HIV replication a 
mutation will likely occur that makes it unique in the population. As described 
earlier, many of these mutants will be selected for or selected against. 
Eventually, the most fit type of virion in the population becomes predominant. 
Many other less common variants remain in the population of virus. These less 
common variants can quickly become the predominant isolate if conditions of the 
host change or additional factors are introduced. An earlier example was the 
administration of antiviral drugs to a patient, providing a strong selection pressure 
for the appearance of variants that are resistant to the drug. These drug 
resistant variants may already be present in the host, albeit at very low levels, 
and because of selection pressure from the antiviral drug, they become the 
predominant type variant in the patient. The quasisviral theory of almost 
unlimited variants of a virus existing in a patient has been observed in many 
different RNA virus systems, and plays an important role in the evolution of the 
virus. 
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CHAPTER 3. ISOLATION AND CHARACTERIZATION OF NEW WILD-TYPE 
ISOLATES OF BOVINE LENTIVIRUS 
A paper published in the Journal of Virology 
David L Suarez"! ,2 Martin J. VanDerMaaten"!, Charles Wood^, and 
Cecelia A. Whetstone"• >4 
Abstract 
Two new isolates of bovine lentivirus, also known as bovine 
immunodeficiency-like virus (BIV), were obtained from a seropositive cattle herd 
in Florida. This is the first report of new isolates of BIV since the original BIV 
strain, R29, was isolated in 1969. The two new BIV isolates were derived from 
blood buffy coat cells cocultivated in vitro with fetal bovine lung (FBL) cell 
cultures. The new isolates differed in vitro from the original R29 isolate in 
replication and syncytial formation in FBL cells. Both new isolates were 
confirmed as BIV by immunofluorescence, Western blot, and polymerase chain 
reaction (PGR). Sequence analyses of the PGR po/gene product showed a 
92.6% and 93.6% homology to the published nucleotide sequence of BIV R29-
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127, a molecular clone derived from BIV R29. Each of the new BIV isolates was 
inoculated into two calves, and virus was recovered between 5 and 10 days post 
inoculation (PI) with BIV seroconversion between 10 and 21 days PI. Vims has 
been recoverable and antibody detectable for at least four months PI. Two 
calves developed a transient, elevated mononuclear cell count, similar to what 
was reported for BIV R29 in the original experimental calf inoculations. No other 
clinical abnormalities have been observed. 
The original isolation of the bovine immunodeficiency-like virus (BIV) was 
made in 1969 from an eight year old dairy cow from Louisiana that had a 
persistent lymphocytosis and was becoming progressively emaciated. At the 
time of necropsy, this cow had clinical and histopathological lesions including 
perivascular cuffing in some vessels in the brain and enlarged lymph nodes and 
hemal nodes (28). The viral isolate from this dairy cow, designated R29, was 
originally described as a Visna-like virus because of similarities to the ovine 
lentivirus. With the finding that the human immunodeficiency virus (HIV-1) was a 
lentivirus, renewed interest in the bovine Visna-like virus resulted in its molecular 
characterization that conclusively placed BIV in the lentivirus family as a unique 
member of the group (4,10,11). 
BIV causes a persistent infection in cattle and serological data indicate 
that it may have a world-wide prevalence (2, 3,13, 14, 29, 30). BIV shares a 
similar genomic organization with other Antiviruses including the pol, gag, env 
and faf genes (10, 24). Antigenically, antisera to BIV p26 cross reacts with p24 
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of HIV-1, and antisera to equine infectious anemia virus (EIAV) cross reacts with 
p26 and p24 of BIV (11,31). Two infectious molecular clones of BIV R29, BIV 
R29-127 and BIV R29-106 have been sequenced, showing that the virus is a 
unique member of the lentivirus family (4,10). BIV R29-106, however, did not 
replicate well in cattle after experimental inoculation (6). 
All molecular characterizations and animal inoculation studies on BIV have 
been completed using the original BIV R29 isolate, which has been passaged 
extensively in vitro or frozen for over 20 years, and it may be attenuated (6, 8, 
10). The R29 isolate has also become contaminated with a noncytopathic strain 
of bovine viral diarrhea virus (BVDV). The original experimental inoculations of 
BIV R29 In colostrum deprived calves induced a mild lymphocytosis and 
enlargement of peripheral subcutaneous lymph nodes, with no overt clinical signs 
of disease (28). In recent studies, using either BIV R29-1203 inoculant free of 
BVDV, or R29 inoculant in BVDV vaccinated cattle, or BIV R29-106 molecular 
clone inoculant, the original experimental observations of leukocytosis and lymph 
node enlargement have not been observed, suggesting that the virus may have 
become attenuated (6,10). Attenuation of lentiviruses in cell cultures has been 
described in detail for EIAV (5, 25). However, the virulence of one EIAV isolate 
was increased with rapid animal passage (25). Similar experiments with BIV 
have not resulted in a change in the course of infection. The BIV R29-106 
molecular clone, which is infectious for cell cultures in vitro, was not sustained by 
animal passage through whole blood transfer (6,10). 
Several studies with BIV have explored the possibility that this virus may 
cause immune system alterations, similar to HlV-1 or feline immunodeficiency 
virus (FIV). However, because the original BIV isolate, R29, has become 
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contaminated with a non-cytopathic strain of BVDV, an RNA virus that can cause 
immune suppression in the bovine, interpretation of data acquired from cattle 
inoculated with this isolate becomes complicated (6,21). Studies examining 
immune function of BIV in vivo have demonstrated either mild or no 
immunosuppression based on lymphocyte blastogenesis tests, neutrophil 
function tests, mononuclear subset analysis, and histopathological changes (6, 8, 
21). Available research results have not shown that BIV is a disease causing 
agent in cattle in experimental inoculations. These reports were all based on 
studies of cattle infected for less than 27 months (6, 8, 21, 28, 29, 30). Thus, the 
possibility that BIV has a long incubation period before causing disease or its 
ability to act as a cofactor in disease can not been ruled out (6, 29). 
In this report we describe in vitro and in vivo characterization of two new 
wild-type isolates of BIV which were isolated from two cows in a seropositive 
dairy herd in Florida. A BVDV free BIV isolate of R29, BIV R29-1203, was also 
used in this study as a positive control to help contrast the differences of the new 
isolates to R29 derived isolates. The R29-1203 isolate was prepared by 
vaccinating a BIV/BVDV negative calf with an autogenous BVDV vaccine 
prepared (Dr. S. R. Bolin, National Animal Disease Center, Ames, lA) from a 
clone of the non-cytopathic BVDV isolated from BIV R29 cell cultures. After the 
calf developed neutralizing antibodies to BVDV, it was inoculated with BIV R29. 
BIV was recovered from blood buffy coat cells, tested both in vitro by cell culture 
methods and in vivo by calf inoculation, found to be free of BVDV, and 
designated BIV R29-1203. 
In vitro characterization of BIV isolates. A Florida dairy herd with BIV 
seropositive cattle was identified by Western blot assay and blood samples in 
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EDTA tubes were taken for virus isolation attempts (31). The blood samples 
were centrifuged, and the buffy coat cells were removed for coculture with fetal 
bovine lung (FBL) cells cultured in a Eagle's minimum essential medium with 
Earle's salts supplemented with 10% fetal bovine serum, polybrene (4ng/ml), 
gentamicin (50M,g/ml), and 0.02% L-glutamine. These cultures were blind 
passaged and/or cultured with fresh FBL cell cultures until the cytopathic effects 
of syncytial formation and cell lysis were observed. Evidence of viral replication 
by syncytial formation was observed in two cultures, FL491 and FL112, after the 
4th blind passage in culture. The two cows from which the isolates were derived 
were seropositive for BIV on Western blot assay, seropositive for bovine 
leukemia virus (BLV) on AGIO and seronegative for bovine syncytial virus (BSV) 
on agar gel immunodiffusion (AGID) (19,22, 31). Continued culturing of FL491 
and FL112 gave increased syncytial formation with limited cell lysis. The new 
isolates showed differences in replication characteristics in vitro as compared to 
BIV R29, including higher cocultivation ratios, longer incubation times between 
passage, and differences in syncytial appearance typified by a decreased 
number of nuclei per syncytia, greater granularity and slower lysis of the syncytia 
as compared to BIV R29 and BIV R29-derived isolates. Syncytial nuclei from the 
new wild-type Isolates often formed a circular pattern in culture which was not 
commonly observed in BIV R29-derived cultures. The BIV R29-1203 isolate 
demonstrated higher cytopathogenicity in cell culture than did the new isolates. 
The FL491 and FL112 wild-type isolates had similar replication patterns in vitro 
with smaller syncytia and less lytic effect on the cell cultures. The replication 
characteristics of the different BIV isolates were maintained in relation to their 
parent strain after animal inoculation. 
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The new wild-type isolates of BIV have biological differences in 
comparison to R29 in vitro, and in vitro characteristics of other Antiviruses have 
been shown to correlate with the virulence in vivo (7). Specifically, the more 
cytopathogenic lentiviral strains in culture are associated with greater in vivo 
virulence in HIV-1 and greater lymphoproliferative change in the ovine Ientivirus, 
Maedi-Visna (7,12,16,17). Different regions of the viral genomes have been 
associated with these in vitro and in wVo characteristics (9,12, 23,32). 
Biological variation should not be unexpected among BIV isolates, and these 
differences are probably controlled by several different areas of the genome. 
FL491 and FL112 were BIV positive by immunofluorescence assay using 
a BlV-specific antiserum and a fluorescein-conjugated rabbit antibovine 
immunoglobulin G , but both isolates were indirect immunofluorescence assay 
negative for BLV and BSV by the same technique (30). Western blot assays, 
using viral antigen prepared as previously described (31), from each of the 
isolates with positive reference control sera were positive for BIV, negative for 
BLV, and negative for BSV. The AGID tests, using positive reference sera for 
BLV and BSV, were negative (data not shown) (19,22). DNA samples for PGR 
reactions were prepared from BIV infected FBL cell cultures using proteinase K 
followed by phenol/ chloroform extraction following standard procedures (20). 
One ug template DNA, 20 pmoles of primer, 1.25 units Taq polymerase (Cetus 
Corp., Norwalk, CT) in a 50 ul reaction were used in a standard PGR reaction 
mixture with first cycle conditions at 940C for 2 min, 51 ^ G for 15 sec, 72^C for 2 
min, followed by 30 cycles of 940G for 45 sec, 51^0 for 15 sec and 720G for 1 
min and a final extension step at 72^C for 10 min. The poi gene (+) sense 
primer 5' ATG CTA ATG GAT TTT AGG OA 3' and the (-) sense primer 5' GAT 
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CCT TGT GGT AGA ACA TT 3' amplified, from BIV R29-1203, FL491, and 
FL112 infected cell cultures, a 242 base pair product (FIG. 1), the size predicted 
from published sequence data and previously reported work (10,15). Southern 
blot analyses using the BIV po/gene specific probe confirmed the identity of the 
PGR products (20). The PGR product was then directly sequenced by purifying 
the product with a Centricon 100 microconcentrator and using 40 ng of DNA with 
Taq polymerase in a dye terminator sequencing system on an automated 
sequencer (ABI Applied Biochemistry 373A DNA Sequencer, performed at the 
Iowa State University Nucleic Acid Center, Ames, lA). Nucleotide sequences 
were analyzed for homology using the Wilbur-Lipman methods (DNASTAR 
program Align). The 212 base pair sequenced PGR products were compared to 
the published sequence for the putative reverse transcriptase gene segment of 
BIV R29-derived molecular clone BIV R29-127 (10). The BIV R29-1203 isolate 
had a 99.6% nucleotide sequence homology with the published sequence, with 
only a single, silent nucleotide substitution. The BIV FL491 and FL112 isolates 
had 93.6% and 92.6% nucleotide sequence homology, respectively, to the 
published BIV sequence , and a 96% nucleotide sequence homology when 
compared to each other. All sequenced products maintained the same open 
reading frame for a segment of the putative reverse transcriptase gene, and no 
insertions or deletions were seen in the sequenced product. The predicted 
amino acid homology for BIV FL491 and FL112 was 93.8% and 92.3%, 
respectively. 
The reverse transcriptase region of the genome is highly conserved 
among other lentiviruses and it is expected that BIV is similar. Comparison of the 
po/gene region of the BIV R29-1203 isolate, which has been through an animal 
Figure 1 Products of PGR amplification (left) of a 242 base pair segment of 
the po/gene from BIV R29-1203 (lanes 1), BIV FL491 (lanes 2) and BIV 
FL112 (lanes 3) and Southern blot hybridization (right) of those products 
using a 32p.|abeled pol gene probe. Negative (lanes 4) and positive 
(lanes 5) PGR controls and molecular size ladder are also shown. 
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passage and over thirty-five passages in ceil culture, to the published sequence 
for BIV R29-127, a molecular clone of BIV R29, demonstrates that BIV R29-1203 
has only a single, silent nucleotide change from the published sequence. This 
suggests that this segment of the reverse transcriptase region may be highly 
conserved in BIV and provides a valuable guidepost in comparing new isolates. 
The new Florida isolates have a 7-8% nucleotide sequence divergence in the 
conserved po/segment when compared to the Louisiana BIV R29-127, 
demonstrating the divergence of these isolates from R29. The new Isolates 
have only a 4% nucleotide sequence divergence between them suggesting that 
they are more closely related field isolates. Comparisons of different HIV-1, 
Visna and FIV isolates show that the diversity of nucleotide sequences of isolates 
generally is greatest when they are from geographically distinct populations (1, 
18,26, 27). In comparison with these three lentivirus groups, the new Florida 
BIV isolates appear to be distinct from the Louisiana isolate, but are not as 
divergent as what can be seen with other geographically distinct lentivirus 
isolates. Sequencing of other BIV isolates will help to determine if the Florida 
isolates are distinct or continuums of the same BIV population. 
In vivo characterization of BIV isolates. Four calves, negative for 
antibodies to BIV.BLV, and BSV were experimentally inoculated with the FL491 
and FL112 isolate. Each calf received BIV infected FBL cells and culture fluids 
intravenously in the jugular vein and subcutaneously in the area around the 
jugular vein as follows: BIV FL491 (Jersey calf 1268 and Holstein calf 848), and 
BIV FL112 (Jersey calves 1275 and 1269). Calves were observed for clinical 
symptoms and blood samples were taken at 3, 5, 7,10.14, 21, and 28 days post 
inoculation (PI) for virus isolation, serology, and leukocyte (WBC) differential 
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counts. Thereafter, the calves were sampled weekly for serologic and WBC 
response and every two to four weeks for virus Isolation attempts. 
All four calves developed BIV specific antibody responses as determined 
by Western blot analysis. Results of western blots of serum samples from calf 
1275 from preinoculation, PI day 35, and PI day 91, and from calf 1268 
preinoculation, PI day 35 and PI day 105, are shown (FIG. 2). Calves 1268 and 
848, inoculated with BIV FL491, developed a BIV specific serological response 
starting at PI day 10 and 20, and virus was recovered from samples starting on 
PI day 10 and 11, respectively. Calves 1275 and 1269, inoculated with BIV 
FL112, both developed a BIV specific serological response starting at PI day 14, 
and virus was isolated from samples by PI day 5 and 7, respectively. Viral 
antigens, prepared from virus recovered from experimentally inoculated calves 
1268 and 1275, were used in Western blot (Fig, 2) and were positive with BIV 
reference sera. Western blot antigens were also tested with both BLV and BSV 
reference sera and were negative (data not shown). 
The WBC response for calves 1275 and 1269, inoculated with FL112, 
showed a transient leukocytosis consisting mainly of mononuclear cells (FIG. 3). 
The WBC response for calves 1268 and 848, inoculated with FL491, was slightly 
increased with an increased percentage of mononuclear cells, but remained 
within the normal range (FIG. 3). The calves had an expected prescapular lymph 
node enlargement on the side that the inoculation materials were injected, but 
showed no other clinical symptoms. 
Preinoculation sera from all calves were negative for neutralizing 
antibodies to BVDV, BLV and BSV, except for calf 848 which had neutralizing 
Figure 2 (Top) Western blot assay reacting BIV reference serum with viral 
antigens prepared from BIV R29-1203 (lane 1), BIV FL491 (lane 2), an 
isolate of FL491 from calf 1268 (lane 3), BIV FL112 (lane 4), and an 
isolate of FL112 from calf 1275 (lane 5). Molecular size markers are 
indicated on the left. (Bottom) Western blot assays of sera from calf 1268, 
inoculated wth BIV FL491, from preinoculation (lane 1), day 35 PI (lane 
2) and day 105 PI (lane 3) and calf 1275, inoculated with BIV FL112, from 
preinoculation (lane 4), day 35 PI (lane 5) and day 91 PI (lane 6). 
Molecular size markers are shown on the left. The 20Kd band, seen in 
pre and post inoculation serum samples from both calves, is not BIV-
specific. 
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FIGURE 3 Comparison of mononuclear and polymophonuclear cell counts in 
two calves that were inoculated with BIV FL112 (calves 1275 and 1269) 
and BIV FL491 (calves 1268 and 848). Calves 1275 and 1269 showed 
the greatest mononuclear cell increase, similar to the WBC increase 
reported in the original experimental inoculations with BIV R29 (31). No 
changes In polymorphonuclear cell population were observed for either 
calf. 
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antibody to BVDV. After inoculation with BIV, the three BVDV seronegative 
calves remained negative for virus neutralizing antibodies to BVDV. AGID tests 
for antibodies to BLV and BSV also remained negative on multiple samples from 
all calves taken from the 7th through the 14th weeks PI. 
The new isolates in experimental inoculations caused a leukocytosis 
similar to what was described in the original experimental inoculations with 
BIV (28). More cattle need to be inoculated to confirm the initial observation 
that these new isolates cause leukocytosis, to rule out the possibility of biological 
variation among cattle. These studies may provide further insight into the 
question of possible attenuation of the BIV R29 isolate and verify that BIV does 
cause a leukocytosis. Results from the current study, as well as from future 
studies performed with these new wild-type isolates, should provide a clearer 
picture of the true effect of experimental inoculation with BIV. 
In conclusion, this study provides information on the biological and 
genetic characteristics of BIV and provides new BIV isolates for experimental 
study. Since it is possible that the original BIV R29 isolate was attenuated 
through multiple cell culture passages, these new, low passage, contaminant 
free, isolates will allow for measurements of possible immune suppression in vivo 
that may more accurately reflect a natural infection. The new isolates of BIV are 
important to continue investigations of the pathogenesis of BIV infections and to 
elucidate the potential role of BIV as a disease agent or as a cofactor in disease. 
The new isolates increase the potential value of BIV as an animal model for 
lentivirus infections. 
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CHAPTER 4. IMPROVED EARLY AND LONG-TERM DETECTION OF 
BOVINE LENTIVIRUS BY A NESTED POLYMERASE CHAIN REACTION 
TEST IN EXPERIMENTALLY INFECTED CALVES 
A paper accepted by the American Journal of Veterinary Research 
David L Suarez, OVM"!. 2 , Martin J. Van Der Maaten, D.V.M."', PhD and 
Cecelia A. Whetstone, PhD"' 
Abstract 
A nested polymerase chain reaction (PGR) test was developed to examine 
infection with the bovine lentivirus, bovine immunodeficiency-like virus (BIV), in 
cattle. Primers were designed to amplify 2 separate regions of the pol and env 
segments of the BIV genome. Two calves were experimentally infected with an 
isolate derived from the original strain of BIV, R29, or with a recent field isolate, 
FL491. Serial blood samples were collected and examined by virus isolation, 
protein immunoblot, and nested PGR. The nested PGR test detected BIV 
infection by 3 days after inoculation, earlier than the other 2 methods, and 
continued to identify infected cattle 9 to 15.5 months after inoculation, even when 
results from virus isolation and serology became negative. Nested PGR also 
detected multiple sized env products in samples obtained later in the infection 
1 Virology Cattle Research, National Animal Disease Center, Agricultural 
Research Service, U.S. Department of Agriculture, PO Box 70, Ames, 
Iowa 50010 
2 Department of Microbiology, Immunology and Preventative Medicine. Iowa 
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from the calf that received FL491, giving evidence that viral quasispecies were 
selected during in vivo replication of the virus. Results indicated that the nested 
PGR test is more sensitive than virus isolation or serology for the detection of BIV 
infection in cattle. 
Introduction 
The bovine lentivirus known as bovine immunodeficiency-like virus (BIV) 
was first described in 1972."' Although BIV has many structural similarities to 
other lentiviruses, it does not appear to be closely related to any member of that 
group.2 Infection by BIV appears widespread in cattle on the basis of serologic 
studies.3-7 Experimental inoculations of sheep, goats^ and rabbits^ with BIV 
has resulted in infection, verified by a humoral immune response. Apparent 
naturally acquired infection in a sheep also has been reported. Isolates of BIV 
have been shown to cause lymphoproliferative changes, including transient 
Increases in mononuclear cell counts'' -"11 and enlargement of subcutaneous 
lymphatic nodules, in experimentally infected cattle."' However, specific disease 
has not been recognized in acutely infected cattle. In one study a possible link 
between BIV infection and decreased milk production in BIV infected dairy cows 
was suggested.^ A direct role for BIV in chronic progressive disease or as a 
cofactor in a specific disease has not been demonstrated. 
One of the difficulties in studying BIV is the lack of a test to accurately 
diagnose infected animals. Virus isolation from naturally infected animals 
remains difficult and unreliable, and currently only 3 different isolates have been 
reported."' >"'"' Serologic tests, including indirect fluorescent antibody and protein 
immunoblot assays, have been the most widely used methods for identifying BIV-
infected animals.3.6,7,12,13 Serious deficiencies, however, are inherent in the 
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use of these tests. Serologic assays cannot detect BlV-infected cattle early in 
the infection, before detectable antibodies are present, or often late in the 
infection, when cattle may lose detectable BlV-specific antibody responses, even 
though virus can still be recovered.The most widely used serologic test is 
the protein immunoblot assay, in which pelleted virus is used as the antigen.®" 
8,11,13 Antibodies to p26, the major gag protein, and gp110, the surface 
envelope protein, are the most important in determining whether an animal is 
seropositive for BIV.8 in cattle experimentally infected with BIV, antibody to p26 
can be detected as early as 14 days after inoculation and antibody 
concentrations peak 6 to 8 weeks after inoculation. The gp110 response is 
usually detected after the p26 response, with the peak in this response 
sometimes observed many months after inoculationl^ 
An extended-cycle PGR test, in which a hot start is used and that directly 
identifies the BIV genome from infected white blood cells, has been described"'4 
and a normal 30 cycle PGR test has been used for amplifying BlV-specific DNA 
from cell culture."! "• 5 For other retroviruses, including bovine leukemia vims, 
human immunodeficiency virus, and feline immunodeficiency virus, nested PGR 
tests have been developed to identify virus in experimentally induced and 
naturally acquired infections, because of the greater sensitivity and specificity of 
the tests."'6""'9 
Because of problems associated with identification of BIV positive animals 
by use of virus isolation and serology, the purpose of the study reported here was 
to develop a direct detection method for BIV infection. 
a Isaacson, J., G. Whetstone, Y. Wannemuehler, et al.. Loss of antibody to 
the major viral core protein in cattle experimentally infected with bovine 
immunodeficiency-like virus. J. Immunol. 1993; 150:234A. 
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Materials and Methods 
Viruses and animal inoculations- A S-month-oid Jersey calf, calf 1268, was 
inoculated iv and sc with cell culture supernatant and with cells from fetal bovine 
lung (FBL) cell cultures infected with FL491, a recently described field isolate of 
BIVJ An 8-week-old Holstein calf, 289, was inoculated similarly with R29-1203, 
an isolate derived from the original strain of BIV, R29J1 302 days after 
infection, calf 289 was hyperimmunized with pelleted virus from R29-1203 in an 
aluminum hydroxide adjuvant; the dose was repeated 2 weeks later. Calves 
were housed in isolation facilities, and had been tested prior to inoculation and 
found to be free of antibodies to BIV, bovine leukemia virus (BLV), bovine 
syncytial virus (BSV), and bovine viral diarrhea virus (BVDV). 
Virus isolation- Blood samples (10 ml) were collected in EDTA containing tubes 
and centrifuged at 800 X g for 20 minutes at 4 C, and buffy coat cells were 
collected for cocultivation with FBL cell cultures in 25 cm2 flasks. These cultures 
were blind passaged and/or cultivated with fresh FBL cell cultures until the 
cytopathic effects (CPE) of syncytial formation and cell lysis were obsen/ed."' 
Cultures were blind passaged 9 times without evidence of CPE before being 
considered negative. Cultures were grown in Eagle's minimum essential medium 
with Earle's salts supplemented with 10% fetal bovine serum, polybrene (4 
mg/ml), gentamicin (50 mg/ml), and 0.02% L-glutamine.^ Uninoculated stock 
cultures of FBL cells and the new isolates were tested and found to be uninfected 
with bovine viral diarrhea virus and mycoplasmas. 
Serology- The R29-1203 virus was used to prepare antigen for protein 
immunoblot assays to detect BIV antibodies, as previously described.® Briefly, 
virus was obtained from infected culture supernatant by ultracentrifugation 
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(100,000 X g for 1 hour) through 40% glycerol phosphate-buffered saline solution 
, pH 7.2. The concentrated virus was suspended in 1 ml of phosphate buffered 
saline, solubilized in 500 mM NaCI; 50 mM Tris pH, 8.0; 5 mM EDTA; 1% Triton 
X-100; 50 |iM phenylmethylsulfonyl flouride, and protease inhibitors, and then 
boiled in 2X treatment buffer solution (0.125 M Tris hydrochloride, pH 6.8; 4% 
sodium dodecyl sulfate: 20% glycerol; 10% 2-mercaptoethanol; 0.0002% 
bromphenol blue) for 5 minutes. Test sera were diluted 1 ;10 in a solution of 10 
mMTris and 150 mM NaCI, pH 8.6 and tested by protein immunoblot, as 
previously described."' 3 Antibodies to bovine leukemia virus and bovine syncytial 
virus were not found by agar gel immunodiffusion assay in pre-and 
postinoculation sera from both calves.20.21 Antibodies to BIV were not found by 
protein immunoblot assay in preinoculation sera from both calves. Positive and 
negative reference antisera against BIV, BLV, and BSV were available (NADC, 
Ames, lA). 
Preparation of DNA. Blood samples (10 ml) from test cattle were collected in 
vacuum tubes with EDTA . Samples were centrifuged, buffy coat cells collected, 
and remaining RBCs lysed in distilled water followed by equal volumes of 2X 
Calcium- and Magnesium- free Hank's balanced salt solution. Treatment with 
distilled water and 2X Hank's balanced salt solution was repeated until all RBCs 
had been visually lysed and the cell pellet was white. Samples were frozen at 
-70 C for later use or immediately suspended in buffer (10 mM Tris, 100 mM 
NaCI, 1 mM EDTA) with 1% SDS. Proteinase K was added, at 100 |ig/ml of 
sample and the samples were incubated in a 37 C water bath for 3 to 6 hours. 
After digestion, samples were extracted with an equal volume of 
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phenol/chloroform in a density gradient'^ system, and the aqueous layer was 
then extracted with an equal volume of chloroform/isoamyl alcohol (24:1). The 
nucleic acid was precipitated and pelleted, and suspended in 100 ^ 1 of molecular-
biology-grade waterc ; Nucleic acid concentrations were determined by a UV 
spectrophotometer. 
Polymerase chain reaction- In each 50 |il reaction, standard PGR buffer and 
nucleotide conditions, 3 mM MgCI, 20 pmoles of each primer (Fig 1), and 1.25 U 
of Taq polymerase were used in both steps of the nested PGR. The first step 
primers in the enu reaction were P01 and 36; second step primers were P02 and 
37. The first step primers for the env reaction were 04 and 06; second step 
primers were 01 and 45. In the first step , 0.5 iig of sample nucleic acid was 
used. In the second step, 2 |il from the first step reaction was added to a second 
reaction mixture and used as the source of DNA. For the env primers, a 
duplicate PGR reaction was performed with only 4 pmol of primers for the first 
step of the reaction and other conditions remaining the same. 
Cycling conditions for the first step PGR were the same for pol and env 
primer sets and included, for the first cycle of the first step, 94 G for 2 minutes, 51 
G for 15 seconds, and 72 G for 2 minutes followed by 30 cycles of 94 G for 45 
seconds, 51 G for 15 seconds and 72 G for 1 minute, with a final extension step 
of 72 G for 10 minutes. Second step cycling conditions started with 1 cycle of 94 
G for 2 minutes, 61 G for 15 seconds, and 72 G for 1 minute, followed by 30 
cycles of 94 G for 45 seconds, 61 C for 15 seconds, and 72 for 1 minute, with a 
final extension step of 72 G for 10 minutes to complete the reaction. Primers to 
^ Phase lock gel 1 Heavy (5'—>3', Inc. Boulder, GO) 
c Omnisolve, EM Science 
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POl 37 04 45 
^5413 5532 ENV Gene 2256 2322 poL Gene 
// 2497 2746 // 59( p 711 14 / 
1 
P02 36 01 06 
Primer POl 5'-ATGCTAATGGATnTAGGGA-3' 
Primer 36 5'-CAnTCTTGGGTGTGAGCTC-3' 
Primer 37 5'-CCITACCCTCCAGGAATTAA-3' 
Primer P02 5'-CATCCTTGTGGTAGAACATr-3' 
Primer 04 5'-CTATGGATCAGGACCTAGAC-3' 
Primer 06 5'-GCCAGCACAAGCAGGAATAT-3' 
Primer 01 5'-TCTATGGTATCTCTGGCTGC-3' 
Primer 45 5'-ATCAATAACGGTGAGATCCA -3' 
Actinl 5'-AGAAGCTGTGCTACGTCGC-3' 
Actin2 5'-CCAGACAGCACTGTGTTGG-3' 
Figure 1 Nucleotide positions of the 5' nucleotide of the poi and env nested 
primers are represented on the bovine immunodeficiency-like virus (BIV) 
proviral genome, on the basis of R29-127 molecular clone sequence.28 
The outer primers for the pol set are POI and 36, and the inner nested 
primers are P02 and 37. The outer primers for the env set are 06 and 04, 
and the inner nested primers are 01 and 45. The positive control actin 
primers are Actinl and Actin2. 
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the bovine actin gene (Fig 1) were used in a separate, single-step PGR reaction 
as a positive sample control. Reaction conditions were the same as those used 
for BIV PGR, and cycling conditions were the same as those used for the second 
step of the nested PGR (annealing temperature 61 G). 
To minimize contamination of samples with PGR product from other 
reactions, we used a laboratory hood for the preparation of the PGR tests, a 
second hood in a different room to add the DNA from the first reaction to the 
second, a third room for the PGR machine, and a fourth room for the analysis of 
PGR products. Gloves and aerosol-reducing pipette tips were used for all PGR 
work. 
Southern blot hybridization- On a 1.5% agarose gel, 20 |il of the PGR product 
was electrophoresed and stained with ethidium bromide. Gels were transferred 
onto a nylon membrane, using standard Southern blot conditions, and DNA was 
fixed onto the membrane by baking at 80 G for 2 hours under a vacuum,22 
BlV-specific DNA probes used included a PUG-5 plasmid with po/insert (BIV 
R29-127: nucleotide position, 1801-3770 ), a PUG-12 plasmid with env insert 
(BIV R29-127: nucleotide position, 5460 -8052 ), and the gene-specific inserts 
excised from the plasmid vectors. Probes were labeled with an enhanced 
chemiluminescence'' direct-labeling system and added at 20 ng/0.125 ml/cm^. 
Prehybridization, hybridization, high stringency washing ( sodium citrate 
0.0015M: sodium chloride 0.015M; and 0.4% sodium dodecyl sulfate at 55 G) 
and detection were performed according to kit protocols.^ X-ray filme was used 
for detection of the chemiluminescent reaction. 
d EGL, Amersham Intn. 
® Hyperfilm-ECL 
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Primer design. The primers in this study were designed by use of a number of 
criteria including matching of primer pairs for similar melting temperatures, 
balancing GC/AT ratios, and absence of inherent secondary structure. Primers 
sequences were chosen to target conserved sequences within the viral genome. 
The rationale used to determine conserved sequences was based on several 
criteria. Ideally, when sequence data from multiple BIV isolates were available 
for the region of interest, conserved areas could be readily identified and primers 
were selected from these regions. However, if only a single sequence was 
available, the DNA sequence was translated in the putative reading frame and 
the antigenic regions of the protein were determined by a computer program^. 
Primers for the surface envgene of BIV were selected in regions predicted to be 
poorly antigenic and assumed to be internal regions of the protein. These 
predicted internal regions have been shown to be a more conserved part of the 
env region of the genome, compared with that of surface protein amino acids.23 
Primers for the reverse transcriptase region of the po/gene were located by use 
of conserved regions of this gene when comparing several lentiviruses.24 
The 3' nucleotide of a primer is the most critical in binding to the template. 
A mismatch at this codon can greatly decrease the ability of the primer to 
efficiently amplify the target sequence.25,26,27 jh© third amino acid codon 
position is the most commonly changed nucleotide because it is the position 
where silent mutations most often occur. Therefore, all primers used in the 
current study were designed so that the 3' nucleotide of the primer was in the first 
or second amino acid codon position of the putative reading frame for the viral 
sequence to be amplified (Fig 2). 
f Protean, DNASTAR 
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Results 
Virus isolation first detected BIV in calves 289 and 1268 at 7 and 10 days 
after inoculation, respectively. Virus was isolated from calf 289 every time that 
virus isolation was attempted after 7 days. The number of blind passages 
required before large numbers of syncytia were observed increased overtime 
from 1 on day 14 to 3 on day 291. Calf 1268 had positive results on virus 
isolation for all samples after 10 days, except on day 197 after inoculation. The 
number of blind passages before large numbers of syncytia were observed also 
increased from 3 blind passages on day 21 after inoculation up to 9 blind 
passages on days 365 and 470. 
5' aggcttCCTTACCCTCCAGGAATTAAggaatgt 3' 
Primer 37 3. tccgaaggaatgggaggtccttaattccttacaS' 
a a -  G L P Y P P G I K E C  
5' cagtgga^gttctaccacaaggatgggtatgta* 
Primer P02 3- gtcaccTTACAAGATGGTGTTCCTACccatacaS-
a . a .  Q W N V L P Q G W V C  
Figure 2 PGR primers were designed to have the 3' nucleotide of the primer 
coincide with the first or second codon position in the protein reading 
frame. The 3' nucleotide of primer 37 (capital letters) is located in the 
second position of the lysine codon (underlined). The 3' nucleotide of 
primer P02 (capital letters) is located in the first position of the asparagine 
codon (underlined). Primer 37 is on the positive sense coding strand of 
the reverse transcriptase gene and primer P02 is on the noncoding strand. 
Figure 3 Protein immunoblot results from serial serum samples from calves 
289 (top) and 1268 (bottom), in which viral antigens prepared from BIV 
R29-1203 were used. Positive control serum from a BlV-infected sheep 
was used for both blots.8 Calf 289 was inoculated with BIV R29-1203, 
and was hyperimmunized twice with concentrated BIV R29-1203 in 
adjuvant. Calf 1268 was inoculated with BIV FL491. Both calves 
developed a strong antibody response to p26, BIV gag protein. 
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Calves 289 and 1268 seroconverted, on the basis of results from protein 
immunoblot.(Fig 3) Antibody to p26 was first detected in calves 289 and 1268 at 
21 and 14 days after inoculation, respectively. In calf 289, antibodies to p26 and 
other BIV gag proteins peaked at 56 days after inoculation and declined to 
undetectable levels after 180 days. In contrast, antibodies to gpl 10 were first 
detected in calf 289 at 41 days after inoculation, and remained detectable 
throughout the study period. After hyperimmunization with pelleted BIV in an 
aluminum hydroxide adjuvant, calf 289 regained a strong antibody response to 
gag proteins. In calf 1268, antibody to p26 peaked at 28 days after inoculation 
and then slowly declined to barely detectable amounts by the end of the study 
period (470 days), with only a questionably detectable antibody response to 
gpl 10 observed from days 28 through 56. Both calves responded to several 
other BIV proteins, including several gag proteins. 
With nested PGR, results of BIV testing of preinoculation samples from 
both calves were negative, but both calves had positive results for BIV at 3 days 
after inoculation. Calf 289 had positive results, using the pol primers, but 
negative results with the env primers, at 3 days. Calf 1268 had positive results 
with env primers, but negative results with the pol primers at 3 days. All samples 
tested from both calves gave positive results with both sets of primers after 3 
days. With the po/primers, predicted product size of 176 base pairs (bp) was 
observed in all samples. In several samples, a product of approximately 425 bp 
was observed, which hybridized with the BIV po/plasmid on Southern blot (Fig. 
4). Nested PGR was performed with a sample from calf 289 at 291 days after 
inoculation. A gel stab of the larger 425 bp product was used as the sample for 
another 30-cycle round of PCR, using a combination of the 4 different pol 
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primers. The 176 bp product was detected with primer combination P02 and 37, 
and a 425 bp product was detected with primers 37 and 36. Product was not 
observed with the other primer combinations. 
Predicted product size for the env primers, on the basis of the published 
sequence for BiV infective molecular clone R29-106, was 385 bp.28 in calf 289, 
analysis of all samples revealed the predicted product size. For calf 1268, a 
single, larger product was observed early in infection, but later 3 separate bands 
that hybridized to the env/probe were observed (Fig 5). A larger band, predicted 
to be the size of a product amplified by use of primers 06 and 04, also was 
detected on several days and hybridized with the eni/piasmid. Differences were 
not observed when the plasmid with insert or the excised insert alone were used 
for detection of the PGR product. Hybridization was not detected 
when selected blots were hybridized with the opposite plasmid probe (eg, env 
plasmid probe with pot PGR blot). 
Discussion 
Except for very early after infection, virus isolation from the cattle in this 
study appeared to be a sensitive test to detect BIV. Gulturing virus from both 
cattle became increasingly more difficult, however, as time after inoculation 
increased. One difficulty with the use of virus isolation to identify animals 
infected with BIV is that more than 2 months of blind passages may be required 
before results are positive, thus requiring a long delay before results for a 
sample can be considered negative. Another major difficulty is that isolation of 
virus from naturally infected cattle is difficult and has only been reported in a few 
animals. 1 "I Numerous attempts to culture virus from other cattle identified as 
being seropositive or PGR positive for BIV have been unsuccessful in our 
Figure 4 Polymerase chain reaction (PGR) amplification of pol gene (left) 
from serial blood buffy coat samples from calf 289 . The predicted 
product size, 176 base pairs, was observed in every sample, starting at 3 
days after inoculation. Polymerase chain reaction products were 
confirmed by Southern blot hybridization (right) using a BIV pol plasmid 
probe. A 425 base-pair band of hybridization observed in several lanes 
resulted from amplification of BIV DNA from primers of the first and 
second reactions. A control without DNA was included to test for product 
contamination, and all results were negative. 
Figure 5 Polymerase chain reaction amplification of the surface envelope 
gene (left) from serial buffy coat samples from calf 1268. From the 
earliest samples, only a single 440-base-pair product was observed, but 
later 2 additional BIV env bands at 500 and 580 base-pairs became 
apparent. All 3 bands hybridized with a BIV env plasmid probe on 
Southern blot hybridization (right). The 1,700-base-pair, BlV-specific 
band observed in some lanes resulted from amplification from primers of 
the first and second reaction. 
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experience. The FBL cell cultures that we used have been the most sensitive 
cell type identified for culturing BIV R29, but they may not be adequate for 
isolating BIV from many naturally infected animals. Virus isolation remains a 
limited tool for examining animals naturally infected with BIV. 
Serologic tests have been the primary means of identifying animals 
infected with BIV, but recent evidence suggests that this method may not be 
detecting all infected animals.''3'9 In our study, we used the protein immunoblot 
test with whole pelleted virus antigen to detect BlV-specific antibodies in infected 
cattle. We observed decline or loss of detectable antibody to the 2 most 
diagnostically important proteins of BIV: p26, the major nucleocapsid gag protein, 
and gp110, the surface protein. In this study, calf 289 lost detectable 
antibody to p26 in just 6 months after Inoculation. If serology were the only 
method used to test for BIV, this calf would have been considered uninfected 
during the first 2 weeks after inoculation, before antibodies could be detected, 
and infection status would be only questionable after 6 months. When this calf 
was hyperimmunized with BIV at 302 days after the original inoculation, it 
produced a strong antibody response to p26 antigen, suggesting that functional 
B cells that could respond to this antigen had not been lost. After day 42 , a 
weak antibody response to gp110 , which persisted throughout the experiment, 
was detected in calf 289. This difference in response to gag and env proteins 
has been described for BIV and other lentiviruses.^^- 29 
By use of a protein immunoblot with whole virus antigen, we detected an 
antibody response to gag p26, but were never able to detect a unequivocal 
9 Isaacson, J., C. Whetstone, Y. Wannemuehler, et al.. Loss of antibody to 
the major viral core protein in cattle experimentally infected with bovine 
immunodeficiency-like virus. J. Immunol. 1993; 150:234A. 
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response to eni'glycoproteins in calf 1268. For both calves the response to 
gpl 10 was less than for p26. Several explanations for this difference are 
possible. First, antigenic differences of the env proteins of the isolates used for 
detection and those that were used to inoculate the cattle were different. The 
surface envelope gene of HIV has been described to have high sequence 
divergence among different isolates that would cause epitope differences that 
could affect antibody detection.23 Second, the whole virus antigen preparation 
may have less env protein compared with gag protein. For HIV, 100 times more 
gag p24 than envgp120 is predicted to be present in whole cell preparations.^O 
Because BIV is also a lentivirus, gp110 is anticipated to be present in less 
amounts than those of p26 in the intact virus. Third, lentivirus env glycoproteins 
are reportedly fragile and easily sheared off during the process of 
ultracentrifugation through a glycerol cushion, this has been reported with BLV.21 
Fourth, glycoproteins are observed as smears on blots because of variable 
amounts of glycosylation of each molecule. This glycosylation effectively 
decreases the concentration of antigen available for detection, and a single sharp 
band cannot be observed. The inability to confidently detect antibodies to gp110 
in the cattle raises some concern about the use of protein immunoblot to detect 
gp110 in clinical samples. Calf 1268, like calf 289, also had a decrease in 
antibodies to p26. Although the test was never considered negative during the 
study period, antibodies may have continued to decrease to undetectable level. 
The nested PGR test was designed to decrease the possibility of false-
negative and false positive results. False negative results were decreased by 
having 2 sets of primers to different areas of the BIV genome, po/and env, used 
in 2 separate PGR tests. This design decreased the possibility that a single test 
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yielding a false-negative result would result in an animal infected with BIV being 
considered uninfected. Use of multiple primer pairs also decreased the 
possibility of sequence variation causing false-negative results. We have 
observed large sequence divergence, especially in the e/7i^ region, among 
different isolates of BIV. When using a DNA polymerase without 3'-5' 
exonuclease activity, a single base pair mismatch at the 3' nucleotide of the 
primer may result in a negative PGR amplification. Other multiple nucleotide 
mismatches between primer and template also can result in poor or no 
amplification of the target sequence. Therefore, the first step of the nested PGR 
reaction was performed at a lower annealing temperature, to allow for binding of 
primer to template even in the presence of a few base pair mismatches. The 
second step of the reaction was performed at higher temperatures, to provide the 
specificity required in the reaction. Having 2 sets of primers allowed for some 
variation in the target with 1 set of primers, but still allowed amplification by the 
other set of primers. The primers were designed to be in conserved areas of the 
viral genome"! "•, on the basis of computer predictions, reported sequences of 
BIV28, and conserved sequence among Ientiviruses24. 
False negative results also were decreased by evaluating multiple 
samples. Multiple samples are important when the target is present at the limits 
of detection for the test. Although nested PGR has been shown to be highly 
sensitive, another lentivirus study has revealed that virus amounts in blood may 
be low during some periods of the infection.SI Therefore, sufficient target may 
be present in 1 sample, but not in the next. Finally, a sample may be considered 
to have negative results because it is not properly prepared for efficient PGR 
amplification. For example, high salt content in the sample may decrease 
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amplification by the polymerase. A positive sample control, using primers to the 
actin gene, was evaluated on all samples with negative results, to assure that the 
DNA was suitable for PGR amplification. False-positive results are a real danger 
when using PGR, because of the enormous power for amplification by this 
procedure, and established laboratory techniques were used to decrease this 
possibility. This includes PGR setup, amplification, and product handling iwere 
performed in separate rooms, PGR consumables were autoclaved before use, 
and all pipet tips used had filters to prevent aerosolization of reagents. The PGR 
product was further confirmed by Southern blot hybridization with plasmid probes 
to rule out non-specific product. 
In this study, PGR results were similar for both cattle, with positive results 
for po/and eni/primers detected after the fifth day after inoculation. Day 3 
samples gave positive results with only the po/gene primers for calf 289 and with 
the envgene primers for calf 1268. Virus amounts in these early samples may 
have been at the limit of detection for the test, with 1 sample having sufficient 
target for a positive amplification and the next sample being deficient in target. 
In the po/test, 2 products were observed in some samples. An additional 
PGR amplification revealed that the larger product was the result of amplification 
of target by carry over primer from the first step reaction to the second step 
reaction. Results of the env test also had similar higher molecular size bands 
predicted by various primer interactions. Decreasing the amount of primer in the 
first reaction from 20 pmol to 4 pmol decreased the number and the intensity of 
these additional bands. 
Different sized e/ivtarget products were detected between calves 1268 
and 289. Target DNA amplified from calf 289 was of the size predicted on the 
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basis of tiie published sequence for BIV R29-106.28 Product from calf 1268 was 
approximately 150 bp larger at early sample dates, but this was the size 
predicted from sequencing of the surface envelope gene of the FL491 isolate. In 
samples obtained from calf 1268 later in the infection, a second and third 
distinct band were observed above the originally predicted band. Neither band 
decreased in intensity when the primers from the first reaction were 
decreased in a confirmatory test. All three bands hybridized to the BIV- specific 
plasmid probes. The highest band is the size that would be predicted by 
amplification of primers 04 and 01, and may represent a reaction of primers from 
the first reaction with the second reaction that was observed with the pol primers. 
The middle band is approximately 50 bp larger than the predicted size fragment 
of FL491, and it cannot be explained by interaction with the primers in this 
reaction. We hypothesize that these products represented different sized 
quasispecies detected in this calf. Sequence variation was observed in the 
surface env region from the original BIV R29 isolate, with an 87-bp difference 
between R29-127 and R29-106.28 Both of the Florida isolates were larger than 
the original R29 isolate in this region of the BIV genome, with FL112 being larger 
than FL491, the BIV isolate used in this study. The larger quasispecies of FL491 
that was detected in later samples from calf 1268 may have been present in the 
original inoculum. As the virus replicated in vivo, these genotypes were 
sufficiently amplified for detection by the nested PGR test in vitro. 
In this study, the nested PGR test was more sensitive than was serology 
or virus isolation for the detection of BIV in experimentally infected calves. The 
BIV infection was detected earlier with PGR than with the other 2 methods, and 
detection of BIV was constant throughout the course of infection. Whether 
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nested PGR with use of the primers described here will have the same sensitivity 
in detecting naturally infected animals is unknown. The nested PGR test will be a 
valuable tool in examining the pathogenesis of BIV in experimentally infected 
animals. 
Acknowledgements 
The authors thank Janet Warg, Dennis Orcutt, Lea Ann Middle, Gene 
Hedburg, Tom Glasson, and Wayne Romp for technical support; and Drs. Janice 
Miller and Steve Bolin for the BIV R29-1203 isolate. 
Supported by the USDA, Agricultural Research Service GRIS 3630-32000-
001-OOD, NIAID Institutional Service Award AI07378, and Public Health Service 
grant GA50159 from the National Cancer Institute. 
References 
1. VanDerMaaten MJ, Boothe AD, Seger CL Isolation of a virus from 
cattle with persistent lymphocytosis. J.Natl. Cancer Inst. 1972:49:1649-1657. 
2. GondaMA. Bovine immunodeficiency virus. A/DS 1992;6:759-776. 
3. Amborski GF, Lo JL, Seger CL. Serological detection of multiple 
retroviral infections in cattle: bovine leukemia virus, bovine syncytial virus and 
bovine visna virus. Vet. Microbiol. 1989:20:247-253. 
4. Black J. Report of the committee on bluetongue and bovine 
retroviruses. Proc. Annual Meeting of the U. S. Anim. Health Assoc. 
1989:93:145-152. 
75 
5. Cockerell GL, Jensen WA, Rovnak J, et el. Seroprevalence of bovine 
immunodeficiency-like virus in a dairy cattle herd. Vet. Microbiol. 1992:31:109-
116. 
6. Horzinek i\/l, Keldermans L, Stuurman T, et al. Bovine 
immunodeficiency virus:immunochemical characterization and serological survey. 
J. Gen. Virol. 1991:72:2923-2928. 
7. McNab WB, Jacobs RM, Smith HE. Serological survey for bovine 
immunodeficiency-like virus in Ontario dairy cattle and association between test 
results, production records and management practices. Can. J. Vet. Res. 
1994:58:36-41. 
8. Whetstone CA, VanDerMaaten MJ, Miller JM. A Western blot assay 
for the detection of antibodies to bovine immunodeficiency-like virus in 
experimentally inoculated cattle, sheep and goats. Arch. Virol. 1991:116:119-
131. 
9. Van Der Maaten MJ, Whetstone CA. Infection of rabbits with bovine 
immunodefiency-like virus. Vet. Microbiol. 1992:30:125-135. 
10. Smith HE, Jacobs RM. Serologic evidence of bovine 
immunodeficiency-like virus infection in a sheep. Can. J. Vet. Res. 1993:57:305-
306. 
11. Suarez DL, Van Der Maaten MJ, Wood C, et al. Isolation and 
characterization of new wild-type isolates of bovine lentivirus. J. Virol. 
1993;67:5051-5055. 
12. Jacobs RM, Smith HE, Whetstone CA, et al. Hematological and 
lymphocyte subset analysis in sheep inoculated with bovine immunodeficiency­
like virus. Vet. Res. Communications. 1994:18:471-482. 
76 
13. Whetstone CA, VanDerMaaten MJ, Black JW. Humoral immune 
response to the bovine immunodeficiency-like virus in experimentally and 
naturally infected cattle. J.Virol. 1990:64:3557-3561. 
14. Nadin-Davis SA, Chang SC, Smith H, et al. Detection of bovine 
immunodeficiency-like virus by the polymerase chain reaction. J. Virol. Methods. 
1993:42:323-336. 
15. Kashanchi F, Liu ZQ, Atkinson B, et al. Comparative evaluation of 
bovine immunodeficiency-like virus infection by reverse transcriptase and 
polymerase chain reaction. J. Virol. Methods 1991:31:197-210. 
16. Ballagi-Pordany A, Klintevall K, Merza M, et al. Direct detection of 
bovine leukemia virus infection: practical applicability of a double polymerase 
chain reaction. J. Vet. Med. 1992:39:69-77. 
17. Momoi Y, Matsumoto Y. Wateri T, et al. Detection of feline 
immunodeficiency virus proviral DNA in feline peripheral blood mononuclear cells 
by the nested two-step polymerase chain reaction. Zbl. Bakt. 1993:279:274-282. 
18. Zazzi M, Romano L, Peruzzi F, et al. Optimal conditions for detection 
of human immunodeficiency virus type 1 DNA by polymerase chain reaction with 
nested primers. Molecular and Cellular Probes 1993:7:431 -437. 
19. Zazzi M, Romano L, Brasini A, et al. Simultaneous amplification of 
multiple HIV-1 DNA sequences from clinical specimens by using Nested-Primer 
Polymerase Chain Reaction. Aids Res. and Human Retroviruses. 1993:9:315-
320. 
20. Malmquist WA, VanDerMaaten MJ, Soothe AD. Isolation, 
immunodiffusion, imnfiunofluorescence and electron microscopy of a syncytial 
77 
virus of lymphosarcomatous and apparently normal cattle. Cancer Res. 
1969:29:188-200. 
21. Miller JM, VanDerMaaten MJ. Serologic detection of bovine 
leukemia virus infection. Vet. Microbiol. 1976:1:195-202. 
22. Maniatis T, Fritsch EF, Sambrook J, eds. Molecular cloning: A 
laboratory manual. Cold Spring Harbor, NY:Cold Spring Harbor Laboratories, 
1982;382-390. 
23. Modrow S, Hahn BH, Shaw GS, et al. Computer-assisted analysis of 
envelope protein sequences of seven human immunodeficiency virus isolates: 
prediction of antigenic epitopes in conserved and variable regions. J. Virol. 
1987:61:570-578. 
24. Gelman IH, Zhang J, Mailman E, et al. Identification and evaluation 
of new primer sets for the detection of lentivirus proviral DNA. AIDS Res. and 
Human Retro viruses 1992 ;8:1981 -1989. 
25. Huang M, Arnheim N. Goodman M. Extension of base mispairs by 
Taq DNA polymerase: implications for single nucleotide discrimination in PCR. 
Nucleic Acids Res. 1992:20:4567-4573. 
26. Kwok S, Kellogg DE, Spasic D, et al. Effects of primer-template 
mismatches on the polymerase chain reaction; Human immunodeficiency virus 
type 1 model studies. Nucleic Acids Res. 1990;18:999-1005. 
27. Norby S, Lestienne P, Nelson I, et al. Mutation detection in Leber's 
hereditary optic neuropathy by PCR with allele-specific primers. Biochem. and 
Biophysical Res. Comm. 1991:175:631 -636. 
78 
28. Garvey KJ, Oberste MS, Elser JE, et al. Nucleotide sequence and 
genome organization of biologically active proviruses of the bovine 
immunodeficiency-like virus. Virology 1990:175:391-409. 
29. Houwers DJ, Nauta IM. Immunoblot analysis of the antibody 
response to ovine lentivirus infections. Vet Microbiol. 1989;19:127-139. 
30. Layne SP, Merges MJ, Dembo M, et al. Factors underlying 
spontaneous inactivation and susceptibility to neutralization of human 
immunodeficiency virus. Virology 1992:189:695-714. 
31. Simmonds P, Balfe P, Peutherer JF, et al. Human 
immunodeficiency virus-infected individuals contain provirus in small numbers of 
peripheral mononuclear cells and at low copy numbers. J. Virol. 1990:84:864-
872. 
79 
CHAPTER 5. IDENTIFICATION OF HYPERVARIABLE AND CONSERVED 
REGIONS IN THE SURFACE ENVELOPE GENE IN THE BOVINE LENTIVIRUS 
Submitted to Virology 
David L. Suarez"! -2 and Cecelia A. Whetstone"' >3 
Abstract 
The surface envelope (SU) of nine different isolates of the bovine {antivirus 
(BIV) were compared for nucleotide and deduced amino acid (aa) sequence 
diversity. Analyses were done both on isolates derived from the original 
reference strain, R29, and on field isolates of BIV. Six conserved and seven 
hypervariable regions were identified. Many of the hypervariable regions were 
located in areas predicted to be on the surface of the SU protein. The SU gene 
comparison among all isolates showed up to a 50% aa sequence divergence. 
When a conserved region of the reverse transcriptase gene was compared 
among 8 of the isolates, there was less than 12% aa sequence divergence. 
When comparing all isolates, the greatest size differences in the SU gene are 
observed in the 2nd hypervariable region (V2) with up to 104 aa difference 
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between the largest and smallest variant. R29-106, an infectious molecular clone 
of the original isolate of BIV, has an 87 bp deletion in V2 as compared with 
prototype isolate R29-127. All R29-derived isolates sequenced for this study had 
a SU gene size similar to R29-106. The four field isolates sequenced for this 
study had SU genes larger than R29-127. R29-derived isolates may not be 
representative of BIV currently present in United States cattle. 
Introduction 
The bovine lentivirus, also known as bovine immunodeficiency-like 
virus (BIV), was first isolated in 1969 from an 8 year dairy cow (Van Der Maaten 
et al, 1972). This original isolate, R29, was the only BIV isolate available for 
study until recently, when two new isolates, FL491 and FL112, were cultured 
from a Florida dairy herd (Suarez et al., 1993). BIV remains difficult to isolate in 
m 
cell culture, and these three isolates are the only cultured isolates widely 
available for study. BIV is known to cause a persistent infection in cattle and it 
appears to be widespread in the U.S. cattle population as well as abroad (Suarez 
et al, 1994), However, the role of BIV in disease still remains unclear. Although 
several conditions are associated with BIV infected cattle, including encephalitis, 
lymphadenopathy, and immunodeficiency (Gonda et al., 1994), these conditions 
have not been reported in experimentally infected cattle. A serological survey of 
Canadian dairy cattle demonstrated a statistical link between BIV infection and 
lower milk yields (McNab et al., 1994). Because lentiviruses typically produce 
chronic and diverse disease, continued research into a possible role of BIV in 
disease is merited. 
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The high mutation rate of lentiviruses as a group is well documented and 
is thought to play a role in their pathogenesis (Temin, 1993). Lentiviruses are 
thought to occur as a quasispecies, where almost every virion is different, due to 
point mutations, insertions and deletions spread throughout the genome (Temin, 
1993). These mutations are often concentrated in certain regions of the genome, 
even though they probably arise randomly across the genome because of both 
the low fidelity of the reverse transcriptase enzyme and recombinational events. 
Specific areas have such high sequence diversity that they were described as 
hypervariable regions. The surface envelope (SU) gene of several lentiviruses, 
including the human immunodeficiency virus (HIV) (Starcich et al., 1986; Modrow 
et al., 1987), feline immunodeficiency virus (FIV) (Rigby, eta!., 1993; Pancino, et 
al., 1993) and the simian immunodeficiency virus (Burns et al., 1991), have 
multiple hypervariable regions. Hypervariable regions are often predicted to be 
on the surface of the SU protein, suggesting that they may be important in 
helping the virus evade host immune response (Salinovich et al., 1986; Levy, 
1993). Hypervariable regions were also shown to be important in several other 
viral characteristics including cell tropism, virulence, growth characteristics, and 
syncytlum-forming ability (Stamatatos et al., 1993; Sullivan et al., 1993). 
The SU gene of BIV has been studied for potential splicing sites and 
immunoreaction. The env gene of BIV is thought to be translated from the 
second initiation codon in the open reading frame of the env region (Garvey et al, 
1990). Studies done using BIV env either from infected cell culture or from a 
baculovirus expression system support the hypothesis of initiation at the second 
potential start site (Rasmussen et al, 1992 Oberste et al., 1993). The env gene 
encodes both the SU gene and the transmennbrane envelope (TM) gene that are 
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thought to be proteolytically cleaved at a RKPR motif. This proteolytic cleavage 
region is similar to that observed in other Antiviruses (HIV) (Garvey et al., 1990). 
Recombinant proteins starting from this second initiation codon demonstrated 
immunoreaction with serum from BIV infected animals (Rasmussen et al, 1992). 
Sequence variability was previously described for a small region of the RT 
gene of R29-derived isolates and the Florida isolates, with up to 7% sequence 
divergence being observed (Suarez et al., 1993). Sequence variability also was 
observed in the SU gene of R29 derived infectious molecular clones, R29-106 
and R29-127. The major difference between the molecular clones was an 87 
b.p. deletion in the 5' end of the SU gene of R29-106 as compared to the 
prototype sequence of R29-127 (Garvey et al., 1990). Variability in size in the 5* 
region of the SU gene also was observed with a nested PGR test of the SU gene 
between a R29-deriv0d isolate, R29-289, and a Florida isolate, FL491 (Suarez et 
al., 1995). 
The purpose of this study is to further define the SU gene of BIV and 
Identify both consen/ed and hypervariable regions of the gene. Analyses of 
nucleotide and amino acid sequence divergence, size polymorphisms, and 
conservation of cystiene and N-linked glycosolation sites are made. Data are 
compared with sequence from a region of the reverse transcriptase (RT) gene, a 
region of the lentiviral genome considered to be highly conserved. High passage 
R29-derived isolates are compared to more recent BIV isolates for size 
differences in the SU gene and the possible implications on experimental 
inoculation studies are discussed. 
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Table 1 BIV Isolates Used in this Study 
Isolate Origin C®" 
in vitro Propagation 
R29-1203 Isolated from cow 1203 (Inoculated with R29) Fetal bovine lung cells 
R29-289 Isolated from cow 289 {Inoculated with R29-1203) Fetal bovine lung cells 
R29-1078 Isolated from cow 1078 (Inoculated with R29-1481) Fetal bovine lung cells 
FL112 Isolated from Florida dairy cow Fetal bovine lung cells 
FL491 Isolated from Florida dairy cow Fetal bovine lung cells 
OK 20 Uncultured isolate from Oklahoma dairy cow^ NA^ 
OK 40 Uncultured isolate from Oklahoma dairy cow^ NA^ 
R29-127 Infectious molecular clone of R29^ Epithelial tracheal primary cell line 
R29-106 Infectious molecular clone of R29^ Epithelial tracheal primary cell line 
R29-ND Molecular clone of Canine thymocyte cell line 
a Sequence derived from PGR amplified DNA from naturally infected animal 
b Not applicable 
c Sequenced obtained from GeneBank 
Methods 
Virus Isolates Virus Isolates used in this study are presented in Table 1. 
Two infectious molecular clones, R29-106 and R29-107, have been previously 
sequenced and the results published (Garvey et al., 1991). An additional 
molecular clone of R29, R29-ND, has also been sequenced and the sequence is 
available from Genbank. All three clones were cloned from integrated provirus 
from cell culture infected with the R29 isolate. R29-106 and R29-107 were both 
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cloned from the same bovine epithelial tracheal cell culture (Braun et al, 1988). 
R29-ND was cloned from persistently infected canine thymocyte cells (Bouillant 
et al, 1989). The R29-1078 virus isolate was recovered 33 months after the cow 
1078 was experimentally infected with blood from a cow infected with a R29-
derived isolate, 1481 (Van Der Maaten et al., 1990)' The R29-1203 isolate was 
previously described as a BVDV-free isolate of BIV (Suarez et al., 1993), and this 
isolate was recovered from an inoculated calf six weeks after experimental 
exposure. The R29-1203 isolate was the inoculum used to infect bullock 289, 
and the R29-289 isolate was recovered 291 days post-inoculation (Suarez et al., 
1995). Two isolates, FL491 and FL112, were cultured from a dairy herd from 
Florida (Suarez et al., 1993). The R29-1078, R29-1203, R29-289, FL491, and 
FL112 isolates were all recovered and maintained in fetal bovine lung primary 
cell cultures. The OK 14 and OK 40 plasmid clones were derived from the same 
sample of blood from a cow naturally infected with BIV from a herd in Oklahoma. 
The blood sample from the Oklahoma cow was collected in vacuum tubes with 
EDTA by a clinician at the Oklahoma State Veterinary College. The sample was 
sent by next day delivery to the National Animal Disease Center, and the WBC's 
were Isolated and the DNA was extracted according to previously described 
methods (Suarez et al., 1995). The Oklahoma BIV isolate has remained 
unculturable. 
PGR and Sequencing Proviral DNA provided DNA from the isolates 
grown in cell culture was PCR amplified and sequenced. The cells were 
proteinase K digested in TNE, phenol/ chloroform extracted, ethanol precipitated 
and quantitated as previously described (Suarez et al., 1995). For the SU gene 
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sequence, 0.5 p-g of template DNA, 20 pmol of primers 93 and 06 (Table 2), 2.5 
units Taq polymerase, 3 mM MgCI, and standard PGR buffer were used in a 100 
ul reaction mixture. The PGR cycling conditions were: 120 sec. at 94 G, 15 sec. 
at 61 0,120 sec. at 72 G for 1 cycle; 45 sec. at 94 G, 15 sec. at 81 G, 60 sec at 
72 G for 30 cycles; and a final extension step of 72 G fori 0 min. For RT gene 
sequence, one microgram of template DNA, 20 pmol of primers 93 and 06 
(Table 2), 2,5 units Taq polymerase, 3 mM MgGI, and standard PGR buffer were 
used in a 100 ul reaction mixture. The PGR cycling conditions were: 120 sec. at 
94 G, 15 sec. at 56 G, 120 sec at 72 G for 1 cycle; 45 sec. at 94 G, 15 sec. at 56 
G, 60 sec at 72 G for 30 cycles; and a final extension step of 72 G for 10 min. 
The RT gene for the OK sample, an uncultured isolate, was sequenced from 
PGR-amplified DNA using a modification of the above procedure. The sample 
was run for 40 cycles instead of 30 cycles with the conditions described above. 
Multiple reaction tubes with the same template were prepared and the PGR 
product was purified for sequencing by repeated washings in a Microcon 100 
(Amicon) with molecular biology grade water (Omnisolve, EM Science). The 
PGR product was sequenced by a dye terminator sequencing system (ABI 
Applied Biochemistry 373A DNA sequencer; performed at the Iowa State 
University Nucleic Acid Center). Specific primers spread throughout the SU gene 
were used to initiate the sequencing reaction (Table 2), 
Cloning The SU gene from the Oklahoma isolate was PGR amplified, 
cloned into a plasmid vector, and sequenced. A nested PGR reaction was 
employed to generate enough PGR product for cloning. The first step PGR 
conditions used 0.5 lig of WBG derived DNA, 20 pmol of primers 93 and 14 
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Table 2 Oligonucleotide primers used for PGR amplification and DNA se­
quencing. Nucleotide positions were based on the R29-127 molecular 
clone map of the BIV genome (Garvey et al, 1991). Primers on the top 
stand represent positive sense primers and bottom strand represent 
negative sense primers. When two sets of primers are represented at the 
same position, the primers are very similar, except that one of the primers 
has a 12-b.p. 5' extension for use in cloning of the SU gene. 
RT Gene SU Gene 
P01 37 93 04 42 45 606 562 63 94 05 
2256 23J 
2^ 
>2 NM740 5413 5533 590 
t97 2746 5689 5748 59 
4 6200 648966616836 
65 62836305 6680 7114 7192 
P 
CV
J 
6 6 2 C 3 C 1 607 < 2 C 8 8(5^614 
Primer 37 CCTTACCCTCCAGGAATTAA 
Primer 36 CATTTCTTGGGTGTGAGCTC 
PrimerPOl ATGCTAATGGATTTTAGGGA 
PrimerP02 CATCCTTGTGGTAGAACATT 
Primer 14 CTCTCCACAACCTTAGCCGT 
Primer 93 TGAGGCAGACAGAATACAGC 
Primer 01 TCTATGGTATCTCTGGCTGC 
Primer 45 ATCAATAACGGTGAGATCCA 
Primer 04 CTATGGATCAGGACCTAGAC 
Primer 06 GCCAGCACAAGCAGGAATAT 
Primer 03 GTTCCTGCCATAGTGAGAGT 
Primer 08 GACATATGGCCACTGGACAC 
Primer 92 ATCATTCACTATGCGGTAGC 
Primer 94 GTGTCCAGTGGCCATATGTC 
Primer 63 TATGAGCTAGCTITGTTATC 
Primer 62 ITCTAGAIGTTTCACCGAA 
Primer 562 CCTGTTAATCAGGTTCAGTTG 
Primer 13 GTTGGAGGTATCGGTGGATA 
Primer 606 GTAATAGTTGCCATGAGAGG 
Primer 607 GGAGGACTGATGAGCATTGC 
Primer 05 GTTGAAGAACACACTGTGCG 
Primer 42 CAUGAUGAUCAUGTATGGATCAGGAGCTAGAG 
Primer 808 GUAGUAGUACUAGGGAGGACAAGGAGGAATAT 
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(Table 2), 1.25 units Taq polymerase, 3 mM Mg2ci, and standard PGR buffer 
were used in a 50 ul reaction mixture. The PGR cycling conditions were: 120 
sec. at 94 C, 15 sec. at 51 G, 120 sec at 72 C for 1 cycle; 45 sec. at 94 G, 15 
sec. at 51 C, 60 sec at 72 G for 30 cycles; and a final extension step of 72 G for 
10 mln. Two ul of the reaction mixture was used as the template for the second 
step reaction with 20 pmol of dUTP modified primers, 808 and 42 (Table 2), 1.25 
units Taq polymerase, 3 mM Mg2GI, and standard PGR buffer were used in a 50 
ul reaction mixture. The PGR cycling conditions were: 120 sec. at 94 G, 15 sec. 
at 51 G, 120 sec at 72 C for 1 cycle; and 45 sec. at 94 G, 15 sec. at 51 G, 60 
sec at 72 G for 30 cycles and a final extension step of 72 G for 10 min. The PGR 
product was used with a ligation independant cloning system (Gloneamp, Life 
Technologies, Inc.) according to manufacturer's instructions. E. coli cells (Max 
Efficiency DH5a, Life Technologies, Inc.) were transformed according to 
manufacturer's instructions. The recombinant bacteria were screened with a 
PGR-based procedure. Plated bacterial colonies were picked and grown 
overnight in 3 ml of LB broth. One ul of the broth was used as template for the 
PGR reaction. The 1 ul of broth was added to 32 ul of molecular biology grade 
water (Omnisolve, EM Science) in a reaction tube and the tube was heated and 
cooled to release the plasmid DNA for PGR. The conditions to release plasmid 
for PGR were: 30 sec at 65 G, 30 sec at 14 G, 90 sec at 65 G, 180 sec at 97 G, 
60 sec at 14 G, 180 sec at 65 G, 60 sec at 97 0, 60 sec at 65 G and 10 min at 80 
G for 1 cycle. Buffer, 20 pmol of primers 01 and 45 (Table 2), MgGI 3mM, 
dNTPs, and 1.25 Taq polymerase units were added after the bacteria were 
processed with the following cycling conditions; 120 sec. at 94 G, 15 sec. at 61 G, 
90 sec at 72 G for 1 cycle; 45 sec. at 94 G, 15 sec. at 61 G, 60 sec at 72 G for 30 
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cycles; and a final extension step of 72 C for 10 min. The PGR products were 
analysed in agarose gel with ethidium bromide staining. Positive clones were 
grown overnight in LB broth and the plasmid was purified using a commercial 
plasmid isolation kit (Perfect Prep, 5 Prime-3 Prime). 
Data Analyses DNA sequence analysis was performed using the program 
SeqMan (DNASTAR). Sequence alignments were performed with the program 
Megalign (DNASTAR) using the clustal method. Rooted phylogentic tree 
analyses were also performed with the Megalign program. Antigenic indexes 
were calculated using the Emini method with the computer program Protean 
(DNASTAR). 
Results 
A total of five RT gene and seven SU gene sequences from different 
sources were examined. An additional three RT and SU sequences were 
available from Genbank and were included in the analyses. The sequences 
derived from R29, which included five RT and six SU sequences, were first 
analyzed separately because of the small amount of sequence divergence that 
was observed. The RT gene showed very little sequence divergence among the 
different Isolates, and only a single amino acid difference was observed in the 
R29-ND sequence. Greater sequence divergence was observed in the SU gene. 
Up to 5% sequence divergence was observed among the R29-derived isolates. 
Phylogenetic tree analyses of amino acid homology and sequence homology 
divided the isolates into two groups (Fig. 1). The first group included R29-127, 
R29-106, and R29-ND, and the second group included R29-1203, R29-289, R29-
1078. Nine amino acid changes, spread throughout the SU gene, separated the 
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R29-derived Amino Acid Comparison 
Figure 1 Pinylogenetic tree analyses of the SU gene of R29-derivecl isolates 
of BIV based on the Clustal method (Megalign, DNASTAR). The top tree is 
based on nucleotide comparisons and the bottom strand is based on amino acid 
sequence comparison. 
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two groups. An 87 nucleotide base pair (29 a.a.) size difference was observed 
between R29-127 and all other R29-derived isolates. 
A second sequence comparison included R29-127, R29-289, FL491, 
FL112, and OK. For the RT gene sequence, a single sequence represents the 
OK sample, because this sample was uniform enough to derive sequence 
directly from PGR amplification of the RT gene. The OK SU gene, however, was 
more complex and was cloned. Two different OK clones, OK 14 and OK 40, 
were Included in the SU gene analyses. 
Among the isolates, the RT gene region had up to 10% divergence in 
nucleotide sequence homology and up to 11 % amino acid sequence divergence 
(Fig. 2). No size variation was observed in any of the RT gene regions 
examined. The sequence variation appeared to be spread throughout the RT 
gene segment, and no areas of either high variability or conservation were 
observed. 
Six sequences were used for the main analysis of the SU gene. The OK 
clones were amplified with a primer that overlaps the first 18 b.p. of the SU gene, 
and this part of the sequence was inferred by the successful PGR reaction. The 
sequences R29-127 and R29-289, FL491, FL112, OK 14 and OK 40. 
Gomparison of a.a. sequence showed diversity as high as 42 % among the 
different isolates (Fig. 2). The variation was not randomly distributed throughout 
the genome, and both conserved and hypervariable regions were identified. A 
conserved region was defined as a region larger than 12 a.a. that had less than 
10% sequence divergence from the consensus. A hypervariable region was 
defined as a region larger than 12 aa with greater than 30% sequence 
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Figure 2 (Top) Percent nucleotide (above diagonal) and amino acid (below 
diagonal) sequence similarities of the RT gene. (Bottom) Percent nucleotide 
(above diagonal) and amino acid (below diagonal) sequence similarities of the 
SU gene. 
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divergence from the consensus. A total of six consen/ed regions and seven 
hypervariable regions were defined (Fig. 3). They are referred to in order as C1, 
C2, C3, etc. for the conserved regions and V1, V2, V3, etc. for the hypervariable 
regions similar to the convention used in other lentiviruses. Five potential N-
glycosylation sites were conserved among all 6 isolates (Fig. 3). The average 
number of potential N-linked glycosolation sites for each isolate was 14.6, with 
R29-289 and OK-14 having the least at 13 and FL112 having the most at 17. 
Nine cysteine residues were conserved among the six isolates (Fig. 3). The 
average number of cysteine residues for each isolate was 13.7, with a low of 12 
for R29-289 and a high of 15 for FL112 and OK 14. Conservation of cysteine 
residues was 66%. 
Large size differences in the SU gene were observed among the different 
isolates. 104 a.a. (312 nucleotide b.p.) separated the smallest and largest SU 
genes. Previously described size differences were observed between R29-127 
and R29-106 (Garvey et al., 1990). All R29-derived sequences examined in this 
study had a R29-106 size genome. SU gene sequences of the four other 
isolates were larger than the R29 isolates, and each differed in size from each 
other. The greatest size differences were in hypervariable regions V2, V4, and 
V7, with the V2 region showing the most variability among all six isolates, 
exhibiting size polymorphisms of up to 76 a.a. Other smaller insertions and 
deletions were spread throughout the SU gene, with most being in the defined 
hypervariable regions. 
Antigenic indexes for the SU protein were calculated and compared to the 
defined hypervariable regions. A close relationship between hypervariable 
regions and predicted antigenic regions were observed. Specifically, in the V2 
Figure 3 Amino acid sequences of the SU gene of six BIV isolates. 
Alignment of the sequences was done with the assistance of Megalign 
(DNASTAR). Numbering of the sequences is given as the total a.a. at the 
ends of the sequence. R29-127 is used as the prototype sequence. For 
the other isolates, dots indicate identity with R29-127, dashes indicate 
the absence of an amino acid. Potential N-glycosylation sites present in 
all isolates are shaded. Symbols: conserved cysteine residues *; 
conserved regions ••• ; hypervariable regions •••••; ovals 
indicate each of the nine amino acid differences that separated the 
culture isolates and the animal-associated isolates of R29. 
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region, with its great size variation, a corresponding widening of the predicted 
antigenic region was seen among the different isolates (Fig. 4). 
Discussion 
As anticipated, a high degree of variation was observed in the SU gene 
among the different isolates. The RT gene was conserved, a finding consistent 
with observations of other lentiviruses (Greene et al., 1993; Levy, 1993). 
The SU and RT genes, representing a total of seven isolates of BIV, were 
sequenced for this paper and an additional three isolates" sequences were 
available from previously reported data and from Genbank. Six of the sequences 
were very similar because they were derived from the same isolate of BIV, R29. 
R29 was originally isolated in 1969 on fetal bovine spleen cells (Van Der Maaten 
et al., 1972). Originally, when this low passage isolate was used for experimental 
inoculations of calves, it did not cause clinical disease, but rather a 
lymphoproliferative response characterized by an increased blood nfiononuclear 
cell count and enlarged subcutaneous lymphatic nodules (Van Der Maaten et al., 
1972). The R29 isolate was eventually frozen and not actively studied until after 
the cause of AIDS was shown to be a lentivirus. The R29 isolates currently 
available have been propagated in several different cell culture types. The 
infectious molecular clones of R29, R29-106 and R29-127, were cultured in and 
cloned from bovine epithelial tracheal cells (Braun et al., 1989), the R29-ND 
isolate was propagated in canine thymocyte cells (Bouillant et al., 1989), and the 
R29-1203 isolate was propagated in canine thymocyte cells, Black 20 bovine 
kidney cells and fetal bovine lung cells (Suarez et al., 1994). The R29 isolate no 
longer causes the same response in experimentally infected cattle as that 
originally described (Van Der Maaten et al., 1972; Carpenter et al., 1992), 
FL112 
OK 40 
Figure 4 Antigenic indexes of the SU gene sequences of three isolates of 
BIV using the Protean computer program (DNASTAR). The three bars under the 
graphs represent the three hypervariable regions with the greatest size 
polymorpisms. 
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possibly because it has been extensively passaged in a number of different cell 
culture types. 
Phylogenetic tree analyses comparing both SU nucleotide and amino acid 
sequence show that the R29 isolates cluster into two groups, the cell culture 
group and the animal inoculated groups. Three isolates, R29-106, R29-127 and 
R29-ND were all isolates that were not passaged through animals before being 
sequenced. The remaining three isolates had all been passaged through cattle 
at least once before being sequenced. R29-289 and R29-1078 had been 
through two animal passages before being sequenced. Based on phylogenetic 
tree analysis. R29-289 was clustered as close to R29-1078 as to R29-1203 
which is surprising, since R29-1203 was used to inoculate the calf from which 
R29-289 was isolated. A total of 9 amino acid changes completely separated the 
cell culture group and the animal inoculated group of isolates. These changes 
were spread throughout the SU gene and were in conserved and hypervariable 
gene regions (Fig. 3). We conclude that the SU gene of BIV is subject to 
selection pressure from both in v/Voand in vitro passage. These potentially 
attenuated viruses have been the only isolates of BIV available for study until 
1993. 
SU gene analysis, focusing on the isolates R29-127, R29-289, FL491, 
FL112, OK 20 and OK40, showed that these isolates also separated into three 
different groups based on their origin (data not shown). The R29-derived isolates 
were the most closely related, even though one was cell culture derived and the 
other was obtained from an inoculated animal. Both Florida isolates came from 
the same dairy herd and they were more closely related to each other than to 
other isolates. The OK uncultured isolates came from the same cow and were 
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isolated from WBCs by PGR amplification and cloning of the SU product. Two 
clones were included in the analyses because they demonstrated a high degree 
of sequence divergence. The six isolates, when aligned to each other, 
demonstrate regions of the SU gene that are either conserved or hypen/ariable. 
Conserved and hypervariable gene regions have been observed in other 
lentiviruses, and have been shown to be important in a number of virus functions. 
The different hypervariable regions were named V1-V7, similar to other 
lentiviruses. Large size differences were observed between the different isolates, 
especially in the V2 region. An 87 b.p. nucleotide difference was observed in the 
R29-derived infectious molecular clones that were originally sequenced. This 
size difference was the only large size difference between these otherwise very 
similar clones. The R29-106 infectious molecular clone size appeared to 
predominate in the cell culture from which these two molecular clones were 
made, since the R29-127 size molecular clones could not be detected in 
restriction enzyme mapping with Southern Blots (Garvey et al., 1990). The 4 
additional R29-derived isolates also had the R29-106 size SU gene. It is 
unknown if any R29-127 sized virus is still present in uncloned viral stocks. 
The V2 region varied by 72 amino acids when comparing R29-289 and OK 
40. The SU gene of OK40 was a total of 104 amino acids or 20 % larger than 
R29-289. Size polymorphisms of the SU gene have also been observed in other 
lentiviruses, with greater variation observed in specific hypervariable regions. 
(Kusumi et al., 1992; Ball et al., 1994, Rigby et al., 1993; Simmonds et al., 1990) 
Although size polymorphisms are common among lentiviruses, the size variation 
of the V2 region of BIV, at 74 a.a. between the largest and smallest Isolates, is 
higher than that observed in other lentiviral systems. The SU genes of R29-
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derived isolates are considerably smaller than more recent field types. The 
Florida isolates are of intermediate size in this collection. It is unknown if the size 
differences observed are related to virus pathogenicity or in the ease of virus 
isolation. The R29-derived isolates, with the smallest SU gene, are the easiest to 
recover in experimentally infected animals (Suarez et al., 1995) and appear non­
pathogenic, not even causing the early mononuclear cell increase that was 
observed in earlier inoculations (Carpenter, 1992; Flaming et al, 1993). The 
Florida isolates, with an intermediate recovery rate from infected animals, cause 
a mononuclear cell increase early in infection (Suarez et al., 1993; Suarez et al., 
1995). The OK isolate has remained unculturable and has not been 
characterized in experimental infections. Caution must be used in the analyses 
and use of data from experiments that have used R29-derived isolates, because 
they may not be typical of what is observed in naturally acquired BIV infections. 
The experimental evidence for hypen/ariable regions in the SU gene of 
BIV is consistent with observations of other lentiviruses. Hypervariable regions 
were consistently located In regions that were predicted to be antigenic, and, 
therefore, on the surface of the protein (Modrow et al., 1987), The surface 
epitopes that are often contained in these hypen/ariable regions may provide a 
selective advantage to the virus by having high antigenic variation that helps it 
evade the host immune response. This appears to be an important mechanism 
for some lentiviruses such as equine infectious anemia vinjs (Salinovich et al, 
1986). Alternatively, these hypervariable regions may be structural scaffolding 
that can tolerate high sequence diversity, similar to that observed on the "rims of 
the canyon" of human rhinoviruses (Chapman et al., 1993). BIV is thought to 
have a generally random mutation process, but it does maintain both consen/ed 
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genes, such as the RT gene, and conserved regions of variable genes, such as 
the SU gene. Therefore, a selection pressure must be present that allows 
mutations to be maintained in the viral genome. However, with the lack of 
knowledge about the role of BIV in disease, it is unclear if these differences are 
important In the pathogenesis of this virus. Continued research into the 
pathogenesis of BIV and the role that viral variation may have on this virus are 
warranted. 
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CHAPTER 6. GENERAL CONCLUSIONS 
The state of knowledge about BIV is heavily weighted to what has been 
determined with R29 or its derivatives, because for over twenty years the R29 or 
R29-derived isolates were the only isolates available for study. However, looking 
at other viral systems, it is well known that the virus isolate used for experinnental 
studies will affect the results observed. For example, the equine infectious 
anemia virus, another lentivirus, has both attenuated and virulent isolates 
described. Adaptation of growth of EIAV to certain cell lines promotes an 
attenuated form of the virus (Carpenter et al., 1989). Other differences in 
pathogenesis of different isolates have also been described for the Maedi-Visna 
virus (Lairmore et al, 1987). These factors illustrate the importance of examining 
new BIV isolates and exploring the possibility that R29-derived isolates may not 
represent BIV isolates found currently in the field. 
To compare R29-derived isolates to other isolates, new isolates needed to 
be cultured. BIV, however, is a difficult virus to culture in presently described cell 
lines. However, two new isolates, FL112 and FL491, were cultured from BIV 
seropositive cows from a Florida herd using essentially the same methods that 
were described for culturing the R29 isolate. The Florida isolates were more 
closely related to each other than to R29, based on sequence comparisons of the 
RT gene, but differed in biological activity. The FL112 isolate had a greater 
mononuclear cell increase after experimental inoculation than did the FL491 
isolate. This early mononuclear cell increase had also been described for the 
R29 isolate of BIV after the initial experimental studies, but in later experimental 
studies this transient mononuclear cell increase was apparently lost (Van Der 
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Maaten, et al., 1972; Carpenter et al, 1992). Further differences observed 
between the Florida isolates and the R29-derived isolates in cell culture included 
differences in syncytial forming capacity in cell culture, and the ease of recovery 
in cell culture of R29-derived isolates compared to the Florida isolates from 
experimentally infected cattle. It is unknown if these biologic differences reflect 
the viral replication rate of the different isolates or the tissue culture adapted 
nature of the R29-derived Isolates. Most, if not all, of the remaining R29-derived 
isolates have been passed through at least two different cell lines and, therefore, 
must be considered highly tissue culture adapted. 
The next step in examining for viral variation was to develop tools to look 
for variation. The nested PGR test was developed as a test to identify infected 
cattle and as a tool to sequence parts of the BIV genome. For these reasons the 
PGR test was developed to examine both conserved and variable regions of the 
BIV genome. The reverse transcriptase (RT) gene was used for the conserved 
region and the surface envelope (SU) gene was used as the variable region. The 
nested PGR test was also compared to the protein immunoblot test and virus 
isolation as methods for detecting cattle experimentally infected with BIV. The 
nested PGR test was more sensitive than the other two methods. A loss of 
antibody to the p26 gag protein was observed with the protein immunoblot test in 
both cattle tested. This loss of antibody has been observed before ® (Whetstone 
et al., 1990; Onuma et al, 1992), and it has the potential to be important 
diagnostically, because current serologic tests rely heavily on the presence of 
s Isaacson, J., C. Whetstone, Y. Wannemuehler, et al., Loss of antibody to 
the major viral core protein in cattle experimentally infected with bovine 
immunodeficiency-like virus. J. Immunol. 1993; 150:234A. 
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antibody to p26 for detection of BIV infection. An additional unexpected finding 
was observed in the PGR results from calf 1268. When examining the envPCR 
product, a detectable shift in the size of the BIV population was observed. The 
nested PGR env primers were directed to amplify a 5' region of the SU gene, and 
in calf 1268 these primers amplified only a single size early in infection, but later 
during infection a larger BIV band representing a larger genotype was detected 
that became the predominant size product observed. An apparent selection 
process for a larger variant appeared to be going on in vivo. 
Direct comparisons of sequences from different BIV isolates has allowed a 
more detailed analysis of differences between isolates. A total of five isolates 
from cell culture, three sequences available from Genbank, and direct PGR 
amplification and/or cloning of BIV from an Oklahoma cow were used in the 
sequence analyses. Six of the sequences were from R29-derived samples. 
When these six samples were analyzed separately, the isolates could be 
differentiated into two groups. The difference in the two groups correlated with 
whether the isolates had been through a recent animal passage. R29-1078, 
R29-1203, and R29-289 all were isolates that had been cultured recently from 
experimentally inoculated cattle, and they had nine amino acid changes from 
R29-127 in common. This analysis provided evidence of an in vitro vs. in vivo 
adaptation process of the different isolates. The R29-derived isolates that our 
group is currently using have a size similar to R29-106 and not to R29-127, and 
the Florida and Oklahoma isolates have a larger SU gene than R29-127. When 
the SU gene of all the isolates were examined, high sequence diversity was 
observed. Similar to what had been observed in other lentiviral systems, the 
variation was concentrated into hypervariable and conserved regions. The 
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mapping of the different regions of the SU gene of BIV should be valuable for 
future experimental studies and aid in the design of new diagnostic reagents. 
The size difference of R29-106 and R29-127 is located in the second 
hypervariable (V2) region of the SU gene. The V2 region also had the greatest 
size variation among all the isolates studied. 
At this time it is not possible to link the biological differences with the 
actual sequence differences, however the data supports several different 
hypotheses concerning BIV. The first hypothesis is that R29 derivatives are 
attenuated. R29-derived isolates no longer cause the same activity in cattle that 
was originally described (Van Der Maaten et al., 1972; Carpenter et al., 1992). 
Also, a definitive pattern of sequence differences appears to have been selected 
for by prolonged cell culture as opposed to animal passage. Both of these 
characteristics suggest that current R29-derived isolates are attenuated similar to 
what has been described for EIAV (Orrego et al., 1982; Carpenter et al., 1989). 
The R29-derived isolates that our group has for experimental inoculations are 
substantially smaller than the Florida isolates and the uncultured naturally 
infected isolates. This provides circumstantial evidence that R29-derived BIV 
isolates do not represent the BIV isolates found in the field. These factors when 
considered together suggest that R29-derived isolates are attenuated, and 
caution must be used when interpreting their use in pathogenesis studies. 
A related hypothesis is that the original R29 that was isolated in cell 
culture predominantly had an SU gene of the same size, or larger, as R29-127, 
and that by continued passage in culture the R29-106-sized SU gene became 
predominant. It was observed when these two infectious molecular clones were 
made that the cell culture contained virus that was predominantly R29-106 in size 
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(Garvey, 1990). The loss of the R29-127-sized genome may account for the loss 
of the mononuclear cell Increase during the early part of the infection process. 
The newer Florida isolates also cause a transient mononuclear cell increase 
early in infection. The hypothesis that the smaller genome size is selected for in 
cell culture can be tested with reagents available today, but the proportion of 
R29-127 sized and R29-106-sized virus in cow R29 or the original cell cultures 
will probably never be known. The additional hypothesis that the size of the V2 
region plays a role in the transient mononuclear cell increase In cattle can also be 
tested with additional animal experiments using BIV mutants constructed with 
wild-type SU gene on a R29 background. 
The hypothesis that the original R29 isolate was predominantly R29-127 
sized and the smaller vaiiant was selected by cell culturing has already been 
stated. We have evidence, in cow 1268, that a larger variant of FL491 was 
apparently selected for in vivo. Additional evidence of selection of the larger 
genotype in vivo was the OK isolate. This isolate has not been cultured and 
when the SU gene was examined in vivo it had the largest SU gene that has 
been sequenced. These data support the Idea of selection of small genotypes in 
cell culture and selection of larger genotypes in vivo. 
The last hypothesis is that the BIV lentiviral system may be unique as to 
the amount of size variation that is observed between different isolates and 
quasispecies in the same animal. Size variation is commonly observed in other 
lentiviruses, but not to the extent that was described with BIV. The V2 region in 
particular has large size variations, and the possible implications as to the 
biological role that this difference may have has been described. The 
identification of conserved and hypervariable regions of the BIV genome will also 
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provide a general framework for associating additional biological features with 
specific sequences and provide additional information for use in diagnostic tests. 
This dissertation looks at viral variation of the BIV genome and provides 
support for a number of different hypotheses about BIV. This report includes the 
isolation and characterization of two new isolates of BIV, but additional isolates of 
BIV need to be cultured to have a more complete understanding of BIV. 
Developing a cell culture system that allows for routine isolation of field isolates 
of BIV, therefore is needed. The role of BIV in cattle disease still remains 
unclear: however, this report does provide evidence that the R29-derived isolates 
may not be the best isolates to use to examine the disease potential of BIV. 
Additional pathogenesis studies with the Florida isolates and future isolates is 
recommended. 
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